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Abstract 
Background: Data suggest that African Americans lose less weight and show fewer 
improvements in cardiovascular diseases such as blood pressure following gastric bypass 
surgery (GBP). 
Objective: The purpose of this study was to describe differences in weight loss between 
Caucasian and African American patients following GBP and to identify if these 
differences are related to dietary intake. This study also sought to identify differences in 
blood pressure and serum lipid levels between African Americans and Caucasians after 
GBP. 
Methods and Subjects: This was a retrospective database review of a sample of 84 adult 
patients, 24 African American and 60 Caucasian women and men between the ages of 33 
and 53 years. All subjects had GBP surgery in 2001 at the Bariatric Surgery Program at 
Boston Medical Center (BMC) in Boston, MA and were followed for one year 
postoperatively. Patients were excluded if weight data were missing at baseline, three 
months and one year following GBP. A total of 9 African Americans and 41 Caucasians 
provided data at all three time points and were included in the study. Weight change was 
calculated using percent of initial body weight and change in body mass index (BMI). 
Differences in dietary intake were determined using dietary records completed by the 
patients or by patient dietary recalls collected by the dietitian. Blood pressure, total 
cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and 
triglyceride levels at baseline and one year were abstracted from the GBP database. 
Results: There were no differences in baseline characteristics between African 
Americans and Caucasians. Caucasians lost more weight (BMI reduced from 56 ± 12 to 
34 ± 8 at one year after surgery with a percent weight loss of 38±8) than African 
Americans (BMI reduced from 54 ± 8 to 40 ± 11 with a percent weight loss of 26 ± 10) 
(p < .001). There were main effects for time and race on weight loss expressed as change 
in BMI and percent weight loss at one year following GBP (p < .001) as well as an 
interaction between and within race weight loss (p < .001). There were no differences 
between races for diet, blood pressure, or serum lipids. However, there were differences 
within race for each of these variables (p < .05). 
Conclusions: These data demonstrate that GBP promotes significant weight loss among 
morbidly obese African Americans and Caucasians. African Americans lost less weight 
at one year after GBP; however, dietary parameters and cardiovascular risk indices were 
not significantly different between races. Prospective intervention studies should be 
conducted to help clarify the primary etiologies for differential weight loss between races 
following GBP. Identification of these causes will help delineate specific interventions 
that are sensitive to racial differences, and ultimately optimize the outcome ofbariatric 
surgery in an ethnically diverse patient population. 
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Introduction 
The incidence of obesity in the United States (US) has reached epidemic 
proportions and is considered a significant public health threat. The National Health 
and Nutrition Examination Survey (NHANES) of 1999-2000 reported that 64.5% of 
adult Americans are overweight with 30% considered obese. Despite increased 
medical awareness of obesity and a multitude of intervention programs, the prevalence 
of obesity has increased more than 75% during the past 25 years (1) with a mortality 
rate of 300,000 deaths annually (2). Obesity predisposes individuals to multiple co-
morbid conditions such as cardiovascular disease (CVD) and type 2 diabetes. The 
incidence of diabetes has increased over the past ten years with 25% of this increase 
associated with obesity (3). Hypertension and dyslipidemia are also associated with 
obesity. The primary cause of mortality associated with elevated BMI is 
cardiovascular disease ( 4). 
Although traditional diets are effective for weight loss between 2-3 kilograms, (5) 
intensive programs with long-term maintenance including diet, exercise, and 
behavioral change strategies can produce 5-10 % weight loss (6). This is generally 
ineffective for Class III obesity (BMI 2: 40 kg/m2) with concurrent co-morbid 
conditions (7). The negative impact of Class III obesity on morbidity and mortality in 
the US cannot be ignored. GBP has been found to be effective for morbidly obese 
patients with subsequent improvements in cardiovascular and metabolic sequelae (7). 
The Roux-en-Y gastric bypass surgery (RYGBP) is now recognized as the gold 
standard treatment for patients with Class III obesity with concurrent co-morbid 
conditions. The RYGBP promotes weight loss by limiting gastric volume and the rate 
of gastric emptying with resultant early satiety (8). This procedure has demonstrated 
sustainable weight loss with manageable complications both in the short- and long-
term (9). 
Studies have demonstrated significant improvements in cardiovascular risk 
factors and diabetes among Caucasian morbidly obese patients following GBP (10). 
Similar studies in other ethnic groups remain limited. This might be related to the less 
frequent use ofbariatric surgery in minority populations (11,12). A small number of 
recent clinical studies suggest that morbidly obese African American women lose less 
weight and show less improvement in blood pressure than Caucasian morbidly obese 
women following GBP (9). Although there might be metabolic differences between 
morbidly obese African Americans and Caucasians, behavioral factors such as dietary 
intake might also account for differences in weight reduction (13). Clarification of 
these differences are important for optimizing the post-surgical treatment of morbidly 
obese African Americans. Due to these racial disparities, it is important that weight 
loss interventions be targeted toward ethnic needs. 
We conducted the following study to compare weight loss between African 
American and Caucasian morbidly obese patients following GBP surgery in an urban 
obesity treatment referral center. We also examined differences in dietary intake and 
cardiovascular risk factors in this patient population before and after weight loss. 
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Methods 
Gastric Bypass Program Protocol 
Screening 
The bariatric surgery program at BMC was launched in 1999, and has since 
performed more than 600 operations. Patients are referred by their primary care 
physician to the Bariatric Surgery Program for screening by the bariatric surgeon, a 
physician board certified in nutrition, a psychologist, and the bariatric registered 
dietitian for surgical clearance. If cleared by all members of the team, preparation for 
surgery includes preoperative weight loss, preoperative and postoperative nutrition 
education, and diagnostic testing. Patients are instructed to follow a low fat, high fiber 
diet prior to surgery to help promote preoperative weight loss and healthy eating 
behaviors. Patients are scheduled for surgery approximately nine to 12 months 
following their initial appointment with the surgeon and must attend at least one 
gastric bypass support group meeting. 
Perioperative and Postoperative Phases 
The hospital stay following surgery is approximately five to six days. The 
surgical procedure performed is a distal RYGB with a 100 to 150 cm Roux limb 
length and 30 mL pouch created in the proximal portion of the stomach. Patients are 
NPO for 48 hours following surgery with advancement to PO ifthe upper GI series 
presents as normal. Subsequently, patients are advanced to sips of water (Stage I) 
followed by a no concentrated sweet clear liquid diet (Stage II), and then to a no 
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concentrated sweet full liquid diet (Stage III), as tolerated. Patients are discharged on a 
Stage III diet and continue to follow this diet at home for three weeks. Patients are 
advised to begin taking chewable multivitamin/mineral and calcium supplements. 
Postoperative follow-up visits are scheduled with both the surgeon and the dietitian 
ten to 14 days following their hospital discharge. At this time, patients will be 
instructed to begin a high protein soft solid diet (Stage IV) at three weeks after surgery 
as tolerated. Patients remain on soft solids for approximately one month, and are then 
scheduled with the dietitian to advance to a low fat solid diet (Stage V), as tolerated. 
Patients continue on the low fat diet indefinitely with modifications made as needed at 
follow-up visits. 
Dietary assessment tools, including the Exchanges for Weight Management 
(14) and dietary logs created by the bariatric dietitian, were provided to patients at 
their initial postoperative visit. The Exchanges for Weight Management provide 
patients with macronutrient analyses including the caloric density of their food and 
beverage intake. Patients were provided dietary logs to record energy, protein, and 
fluid intake. During each follow-:up dietitian visit, food and beverage models were 
used as visual aids to better assess the reliability of portion sizes noted in patient-
reported dietary logs or recalls. The bariatric dietitian reviewed all dietary logs and 
recalls. Patients are advised to consume a minimum of 60 grams of protein from high 
biological value sources and two liters or more of sugar-free non-caffeinated fluids 
daily. Patients are encouraged to document energy intake if there is a decrease in the 
rate or degree of their weight loss. Postoperative follow-up visits with the surgeon are 
scheduled every four to six weeks for the first year or until patients are weight stable, 
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and yearly thereafter. Postoperative follow-up visits with the dietitian occur monthly 
for the first six months and every six months thereafter. 
Subjects 
This retrospective study included African American and Caucasian patients 
who had GBP in 2001 at BMC located in Boston, Massachusetts. A total of 84 patients 
completed surgery during this period including 52% Caucasian women, 20% 
Caucasian men, 23% African American women, and 5% African American men 
between the ages of 31-55 years of age. Patients were excluded if baseline, three 
months or one year postoperative weight data were missing. A total of nine African 
Americans and 41 Caucasians provided complete data and were included in this study. 
There were no differences in age, gender, and proportion with dyslipidemia, 
hypertension, and diabetes mellitus between the 50 subjects providing complete data 
and the 34 subjects excluded from the study for incomplete data. The non-completers 
included 19 Caucasians and 15 African Americans. Those subjects presenting with 
incomplete weight data had a lower preoperative mean BMI (50 ± 9) compared to 
those with complete data. 
The University of Rhode Island and Boston Medical Center Institutional 
Review Board approved this study. 
Measurements 
Body weight in kilograms was measured at baseline (preoperative visit), three 
months and one year after GBP. Body weight was measured using a Scale-Tronix 
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digital scale calibrated every 12 weeks. Height was measured in centimeters using an 
attached vertical rod. 
The bariatric dietitian collected dietary records or dietary recalls from patients 
at baseline and each postoperative visit. Dietary protein and energy intake for each 
visit were calculated using the Exchange Lists for Weight Management (14) and 
Bowes' and Church's Food Values of Portions Commonly Used (15). 
Blood pressure and lipid profiles in both ethnic groups were assessed at 
baseline and one year following GBP. Blood pressure was.measured using a 
baumamometer Standby model (W.A. Baum CO, Inc.) in a postural position. A 
certified phlebotomist collected blood samples with subjects in a postural position. 
Blood was taken from an antecubital vein following a 12-hour fast. Low-density 
lipoproteins (LDL) were calculated using the Friedewald equation if triglycerides were 
below 400 mg/dL (16). Total cholesterol, high-density lipoproteins (HDL), and 
triglyceride levels were measured using the Ektachem DT II System. HDL cholesterol 
levels were then determined by the precipitation method (17). 
Data Analysis and Statistics 
Data were collected from the GBP database and analyzed using the SPSS 
software version 10.5. Means and standard deviations for all parameters were 
calculated. Weight and dietary intake were assessed at baseline, three months, and one 
year after GBP. Primary comparisons were changes in these variables compared 
between the African American and Caucasian groups at three months and one year 
following GBP using ANOV A for repeated measures with ethnicity as a between 
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subjects factor and time as a within subjects factor. This determined changes over time 
in the above variables as well as ethnicity main effects and ethnicity by time 
interactions. Weight data were expressed as percent of initial body weight and BMI. 
Baseline body weight was defined as subject's preoperative weight taken two weeks 
prior to surgery. Protein intake was expressed as percentage of total kilocalories and 
energy intake was expressed as kilocalories per kilogram of body weight. Weight and 
protein and energy intake were assessed at three months and one year after surgery. 
Changes in health parameters were assessed at baseline and one year after GBP by 
paired t-tests comparing changes within and between groups. 
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Results 
Subjects 
Baseline anthropometric and demographic characteristics of participants 
providing complete weight data are summarized in Table 1. There were no differences 
between race in age, BMI, female/male ratio, and prevalence of dyslipidemia, 
hypertension, and diabetes. All subjects had at least one of the noted comorbidities 
with hypertension ( 4 7 % ) being the most prevalent. The average patient seeking 
bariatric surgery was 43 years old with a BMI of 55 kg/m2 . 
Subjects providing incomplete weight data at three months and one year after 
GBP were not different by race in all measured variables, except for a lower baseline 
BMI, compared to those subjects providing complete weight data. 
Weight Loss 
The observation period for this study was one year following GBP. The mean 
preoperative BMI for African Americans and Caucasians was 54 ± 8 (N = 9) and 56 ± 
12 (N = 41), respectively. Both African Americans and Caucasians significantly 
reduced their BMI and percent body weight (p < .001). There was an overall effect of 
' 
race on BMI and percent weight loss with Caucasians losing more weight than African 
Americans (P < .001). Post hoc analyses demonstrated no ethnic differences in BMI 
and percent weight loss between the races at baseline or three months following 
surgery but differences were observed at one year (p < .05) as shown in Table 2. On 
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ge Caucasian patients lost six percent more weight at three months (NS) and 12 avera , 
% more weight at one year (p < .001) after GBP than African Americans. 
Dietary Intake 
As shown in Table 3, African Americans and Caucasians did not differ in 
dietary intake after GBP as measured by energy (kilocalories) per kilogram and 
percentage of energy as protein at three months and one year following surgery. The 
mean energy intake in kilocalories at baseline and one year after GBP was lower in 
Caucasians (2596 ± 588 and 1123 ± 349, respectively) than in African Americans 
(2700 ± 722 and 1368 ± 349, respectively). However, at three months after surgery, 
Caucasians consumed more kilocalories than African Americans (704 ± 238 and 621 ± 
127, respectively). African Americans had a 70 % and 33 % decrease in energy intake 
at three months and one year after GBP, respectively. Caucasians had a 67 % and 31 
% decrease in energy intake at three months and one year, respectively. The mean 
protein intake in grams at baseline and one year after surgery was higher in African 
Americans (83 ± 17 and 61 ± 12; respectively) than Caucasians (82 ± 19 and 59 ± 12, 
respectively). There was no difference in protein inake between races at three months 
after surgery. However, Caucasians consumed more grams of protein than African 
Americans (Caucasians 62 ± 14 and African Americans 53 ± 9; p > .05). Both races 
consumed significantly less energy and more kilocalories as protein at three months (p 
< .001, P < .001, respectively) and one year (p < .001, p < .001, respectively) after 
surgery compared to their intake prior to surgery. Using ANOV A for repeated 
measures, main effects of race were not indicated for changes in energy per kilogram 
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and percentage of energy from protein one year after GBP. However, main effects of 
time on energy intake per kilogram and percentage of kilocalories as protein were 
significant for African Americans and Caucasians (p < .001). 
Cardiovascular Risk Differences 
Differences in blood pressure and lipid values between African Americans and 
Caucasians are detailed in Table 4. There were significant improvements in blood 
pressure and all lipid serum indices within both races one year following surgery (p < 
.01) indicating decreased cardiovascular risks. There were no differences between 
races in diastolic and systolic blood pressure at baseline and one year following GBP. 
Similarly, there were no differences between races in serum total cholesterol, HDL 
cholesterol, calculated LDL cholesterol, and triglycerides at baseline and one year 
following surgery. ANOV A for repeated measures did not show main effects of race 
for blood pressure (systolic and diastolic) and serum lipids (total cholesterol, HDL 
cholesterol, LDL cholesterol, and triglycerides). 
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Discussion 
This study showed significant weight loss at one year following GBP among 
the entire sample. There were differences in weight loss between races with African 
Americans losing 12% less weight compared to Caucasians at one year after GBP; 
African Americans and Caucasians lost a mean total of 44 and 61 kilograms at one 
year after surgery, respectively. These results are similar to those found by Sugerman 
and Latner et. al. (18, 19). The etiology for this difference is still unclear; however, it 
has been suggested that genetic, environmental, behavioral, psychosocial, cultural, and 
metabolic differences contribute to this disparity (20). 
This study observed a significant decrease in energy intake at three months and 
one year within each race following GBP. This is expected following GBP due to the 
reduced gastric pouch capacity (21, 22). Our findings of similar energy intake between 
races at each observed time point following GBP suggest the possibility of metabolic 
differences between races. Other studies have found that African American women 
appear to adapt to energy deficits more efficiently than Caucasian women; they 
require fewer calories for weight maintenance and have a reduced rate of weight loss 
on hypocaloric diets compared to Caucasian women (23-25). Carpenter et. al. found 
lower basal metabolic rates and activity energy expenditure (AEE) in African 
Americans (26). Weisner et. al. found that AEE was significantly different between 
races with African Americans having a lower AEE following weight loss. Caucasians 
showed greater improvements in V02 max, physical activity, and energy expenditure 
(EE) compared to their African American counterparts in response to diet and exercise 
11 
. ht loss interventions (27). These findings have been shown in other studies (28, 
we1g 
29) suggesting decreased weight loss efficiency among African American women 
compared to Caucasian women. Our study did not evaluate differences in physical 
exercise and energy expenditure. Future intervention studies exploring the behavioral 
and metabolic effects on weight loss are needed to further understand the influences of 
ethnicity on weight reduction following bariatric surgery. 
Results from this study showed a significant decrease in energy intake with an 
increase in percentage of kilocalories from protein within each race at three months 
and one year after GBP. Moize and colleagues also observed these postoperative 
dietary changes. Due to the reduced capacity of the gastric pouch energy intake 
significantly decreases, especially during the first six months to a year following GBP. 
High biological value protein sources are encouraged to promote postoperative healing 
and to preserve and restore lean body tissue (30). Modular protein supplements were 
recommended if daily protein intake was less than 60 grams daily, especially during 
the first six months following surgery. Six out of the nine African Americans 
consumed less than 60 grams .of protein at three months after surgery, potentially 
resulting in decreased visceral protein stores and wound healing. Despite the greater 
weight loss among Caucasians, we found no ethnic differences in energy and 
percentage of calories from protein at each observed time point. This was also 
observed in other studies (31, 32) and might be due to under-reporting of energy 
intake among African Africans as shown by Lovejoy et. al. (33). Latner and 
colleagues found that African Americans and Caucasians lost 62 % and 80 % of 
excess BMI following GBP, respectively, but African Americans consumed overall 
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kl.localories than Caucasians with no differences found in exercise frequency fewer 
(1 9). The utility of self-reported dietary intake to assess energy and macronutrient 
intake might have lead to a 20-50 % error of actual intake (34), which was a major 
limitation in most of these studies. Future research can improve the accuracy of actual 
dietary intake by use of doubly labeled water methods (29, 35) or by designing more 
controlled dietary interventions. 
This study examined ethnic differences in cardiovascular disease risk factors 
following GBP. Presently, there are limited data comparing the effect of weight loss 
on cardiovascular risk between African Americans and Caucasians following bariatric 
surgery (35). Our results did not show differences between race in serum lipid profiles 
at baseline and one year following GBP. However, we did find a greater percentage of 
African Americans compared to Caucasians with dyslipidemia at baseline ( 44 % and 
35 %, respectively). Finally, HDL levels were greater at baseline and one year 
following surgery but were not statistically different between races. The small African 
American sample size might have affected the reduced ability of this study to find 
statistically significant differences, but the effect of size for race was low suggesting 
that a larger sample size might not have found differences . Irrespective of BMI, data 
have shown that African Americans as compared to Caucasians have higher HDL 
levels with a subsequent lower risk for CVD (36, 37). 
Our findings suggest no difference in cardiovascular risk factors between 
races. Residori and colleagues reported that African Americans had the highest 
incidence of hypertension compared to Caucasians and other ethnic groups 
independent ofBMI (20). That study did not examine subjects having undergone 
13 
GBP. Sugerman et. al. found that hypertension improved in most subjects with weight 
Joss at one to two years following GBP. However, African Americans responded less 
favorably to improvements in hypertension following GBP induced weight loss as 
compared to Caucasians (35) . There were several limitations of our study. First, the 
small sample of African Americans studied compared to Caucasians. We might have 
observed the same results as Sugerman et. al. with a larger African American sample 
size. Secondly, the effect of medications that subjects might have been taking 
indicated by their medical condition was not monitored in this study. 
In conclusion, our data confirm that morbidly obese African Americans tend to 
Jose less weight following gastric bypass surgery in comparison to Caucasians. These 
differences in weight loss appear to be related to lower energy expenditure and not 
dietary intake. However, despite smaller weight losses among the African Americans, 
improvements in cardiovascular risk factors are similar between the two races. 
14 
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Table 1 
Baseline Characteristics of Subjects by Race 
-
African Americans 
N 9 
Age (Mean±SD) 43±10 
BMI (Mean±SD) 54±8 
Female/Male % 78/22 
Dyslipidemia % 44 
Hypertension % 44 
Diabetes Mellitus % 44 
N =subjects with weight data at baseline, 3 months and 1 year 
BMI =body mass index; calculated as kg/m2 
21 
Caucasians 
41 
43±10 
56±12 
73/28 
35 
50 
25 
N 
N 
Table2 
Body Mass Indices and Percent of Weight Loss Up to 1 Year Following GBP 
N 
Preop 
Post3 
BMIT* 
kg/m2 
9 
54±8 
50±9 
African Americans 
% intial body weight F 
( % weight loss ) 
9 
100 (0) 
91.4±7.4 
months (-8.7±7) 
Post 1 ab40±11 73.9±9.6 
year ab (-26±9.6) 
All data are means ± SD; N = subjects without missing data 
BMI = body mass index; calculated as kg/m2 
Weight loss = % of initial weight 
*F (dfhypothesis, df error), p by repeated measures 
1. 130 (2, 47), p = 0.000 for time; 7.6 (2, 47), p = 0.001 for race x time 
2. 280 (2, 47), p = 0.000 for time; 12.3 (2, 47), p = 0.000 for race x time 
Caucasians 
BM11* 
kg/m2 
41 
56±12 
48±11 
ab34±8 
% initial body weight 2* 
(% weight loss) 
41 
100 (0) 
85.4±3.8 
(-15.2±5.5) 
61.7±7.9 
ab (-38±7.9) 
N 
w 
Table3 
Energy and Protein Intake Before and Up to 1 Year Post GBP. 
African Americans Caucasians 
kilocalories/kilogram 1 * % kilocalories from protein2* Kilocalories/kilogram1• % kilocalories from protein2* 
N 
Preop 
Post 3 
months 
Post 1 year 
9 
16±5 
*5±2 
*12±4 
9 
13±2 
**33±8 
**23±7 
All data are means ± SD; N = subjects without missing data 
*F (dfhypothesis, df error), p by repeated measures 
1. 126 (2, 45), p = 0.000 for time; 1.530 (2, 45), p = 0.230 for race x time 
2. 67 (2, 45), p = 0.000 for time; 0.424 (2, 45), p = 0.657 for race x time 
41 41 
17±4 13±2 
*6±2 **37±12 
*12±4 **23±9 
Preoperative and 1 Year Postoperative Cholesterol and Blood Pressure Values 
African Americans Caucasians 
Preop Post 1 year Mean Change(95%Czy1l Preop Post 1 year Mean change 95%(CI) (tl 
TC 220±19 181±33 -35(-10, -61) * 199±33 179±35 -21(-10, -32)* 
(7) (7) (40) (40) 
N HDL 56±17 66±21 10(25, 5)** 48±10 54±16 6(10, 2)** 
+:- (6) (6) (33) (33) 
LDL 132±7 107±37 -25(-29, -79)** 120±32 103±31 -17(-6, -28)** 
(5) (5) (35) (35) 
TG 130±57 80±24 -50(-4, -96)** 159±55 109±53 -50(-26, -74)** 
(7) (7) (37) (37) 
Sys 136±18 117±15 -19(-3, -35)* 135±23 123±20 -12(-6, -1 8)* 
(9) (9) (41) (41) 
Dias 82±7 70± 8 -12(-4, -19)* 84±12 73±11 -11 (-7, -15)* 
(9) (9) (41) (41) 
All data are means± SD; N =subjects without missing data; 
TC= total cholesterol; HDL = high density lipoproteins; LDL = low density lipoproteins; TG =triglycerides 
Sys = systolic blood pressure; Dias = diastolic blood pressure 
( 1) Mean Change = negative markers indicate decreases 
*P < .001; **P < .01 within race 
Appendices 
Appendix A Literature Review 
Introduction 
The incidence of obesity in the United States (US) has reached epidemic 
proportions and is considered a significant public health threat. The National Health 
and Nutrition Examination Survey (NHANES) of 1999-2000 reported that 64.5% of 
adult Americans are overweight with 30% considered obese. Despite the increased 
medical awareness of obesity and a multitude of diet and exercise intervention 
programs, obesity prevalence has increased by more than 75% during the past 25 years 
(Flegal Km, Carroll MD, Ogen CL, Johnson Cl, 2002) with a mortality rate of 300,000 
deaths yearly (Allison DB, Fontaine KR, Manson JE, Stevens J, Vanltalle TB, 1999). 
I. Obesity 
A. Classification of Obesity and C.omorbidities 
According to the World Health Organization (WHO) obesity is a disease that 
affects all ages, both genders, and all ethnic groups. WHO classifies weight status 
based on BMI, which is defined as weight in kilograms divided by height in meters 
squared (WHO, 2000). Obesity is defined as a BMI of ::::30 kg/m2 and morbid obesity 
as a BMI of ::::::40 kg/m2 with the risks for morbidity and mortality being greatest at a 
BMI of ;::::40 kg/m2 (WHO, 2000). The diagnosis of diabetes has increased during the 
Past ten years with 25% of this increase associated with obesity (Harris ML, Flegal 
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J(M, Cowie CC, Eberthardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt 
DD 1998). Hypertension, dyslipidemia, and metabolic syndrome are highly associated 
with obesity. The primary causes of mortality associated with elevated BMI are from 
cardiovascular diseases (Troiano RP, Frongillo EA, Sobal J, Levitsky DA, 1996). 
B. Etiology 
Obesity is a condition influenced by genetic, psychosocial, metabolic, cultural, 
and behavioral factors (NIH, NHLBI, 1998). Although genetic predisposition plays a 
role in the expression of obesity, genetic factors cannot explain the exponential rise in 
obesity over the past two decades. Behavioral and environmental factors are the most 
probable causes for the expression of genes associated with obesity (Mun EC, 
Blackbum GL, Mathews JB, 2001). Some of these factors include reduced physical 
activity and the availability of high calorie foods resulting in positive energy balance 
(Harnack LJ, Jeffery RW, Boutelle KN, 2000; Flegal Km, Carroll MD, Ogen CL, 
Johnson Cl, 2002). Energy intake and output are difficult to quantify, therefore it is 
important to further examine all causal factors involved such as cultural, 
socioeconomic, psychological, and metabolic influences (Flegal Km, Carroll MD, 
Ogen CL, Johnson Cl, 2002). 
i. Genetics 
Body adiposity is influenced by the interaction of genotype and environment. 
Data suggests that at least 40% of body mass is genetically determined (Bouchard C, 
Perusse L, 1993). This has been examined in twin, adopted, and family studies 
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(Lefebvre pJ, Scheen AJ, 2001). Based on a series of twin studies, Bouchard 
Sted that 25-40% of body weight regulation might be related to genetic factors sugge 
(Bouchard C, 1994; Bouchard C, Tremblay A, Despres JP, Nadeau A, Dussault J, 
Moorjani s, Pinault S, Fournier G, 1990). 
ii. Cultural/Socioeconmic 
Data suggest that an inverse relationship exists between obesity and 
socioeconomic status (Sobal J, Stunkard AJ, 1989). The reasons for this association 
might be due to childhood experiences such as parental neglect (Lissau I, Sorensen 
TIA, 1994) indigent residence (Lissau I, Sorensen TIA, 1994), and social isolation 
(Kinra S, Nelder RP, Leweendon GJ, 2000). In addition, a relationship between 
socioeconomic hierarchy and BMI has been observed. Data has shown that people of 
higher socioeconomic status have a lower prevalence of obesity in part due to their 
heightened interest in health and fitness (Wardl J, Griffith J, 2001). Other factors 
involved include the higher financial expense to eat healthy including foods such as 
fresh fruits and vegetables. Data sµggest that people of lower socioeconomic status 
tend to purchase economical foods, which are most often higher in fat and calories 
potentially leading to weight gain (Drewnowski A, 2003). 
Cultural and ethnic factors have been associated with obesity. Minority groups 
have had a higher increase in obesity as compared to Caucasians with the exception of 
Asians (Drewnowski A, 2004). African American women have the highest prevalence 
of obesity compared to other minority groups (Flegal Km, Carroll MD, Ogen CL, 
Johnson Cl, 2002). The reasons for this disparity are still unclear; however, evidence 
27 
. to physical inactivity (Weisner RL, Hunter GR, Heini AF, Goran MI, Sell SM, 
paints 
1998) as a primary factor as well as lifestyle, environment, genetics, race, and energy 
metabolism (Lovejoy JC, Champagne CM, Smith SR, de Jonge L, Xie H, 2001). 
iii. Psychological 
According to the NHANES, depression is associated with an increased 
prevalence of obesity in the US (DiPietro L, Anda RF, Williamson DF, Stunkard AJ, 
1992). The psychological influences on the onset of obesity include both mental health 
status and the use of psychotropic medications. These medications block the receptors 
for neurotransmitters associated with weight regulation, such as serotonin, resulting in 
potential weight gain (Devlin MJ, Yanovski SZ, Wilson GT, 2000). In addition, 
people with depression often rely on eating to improve their mood resulting in weight 
gain (Wurtman RJ, Wurtman JJ, 1998). 
iv. Behavioral and Environmental (Diet and Physical Activity) 
Positive energy balance is.the primary cause for increased adiposity (NIH, 
NHLBI, 1998). Energy intake has increased over the past two decades most likely 
from the increased consumption of meals away from the home, the availability of high 
calorie snack foods and convenience foods, and an increase in portion sizes (Young 
LR, Nestle M, 2002). These foods include high fat foods, added sugar in snacks (Zizza 
C, Siega-Riz AM, Popkin BM, 2001), sugared beverages (Harnack L, Stang J, Story 
M, 1999), and fast foods (French SA, Story M, Jeffery RW, 2001). WHO suggests that 
high-energy dense foods such as fast foods have significantly contributed to the global 
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. pidemic (WHO, 2003). This was supported in a secondary analysis of the 
obesity e 
cA.RDIA Study. Subjects who ate fast foods more than twice a week over 10 years 
. d an extra 4.5 kilograms of body weight compared to those subjects consuming game 
fast foods less than one time per week (Pereira MA, Kartashov AI, Ebbeling CB, Van 
Hom L, Slattery ML, Jacobs DR Jr, Ludwig DS, 2005). 
Studies have shown a negative relationship between BMI and physical activity 
(Gortmaker SL, Must A, Sobol AM, Peterson K, Colditz GA, Dietz WH, 1996). A 
sedentary lifestyle promotes weight gain by decreasing energy expenditure. Data 
suggest that inadequate physical activity is strongly associated with weight gain in 
both genders. This was shown in a study lasting a decade and included adult subjects 
between the ages of 25 and 7 4 years. Subjects who were inactive were more likely to 
gain between three and four times more weight than the active subjects (Williamson 
DF, Madans J, Anda RF, Kleinman JC, Kahn HS, Byers TJ, 1993). The sedentary 
behavior most likely to promote weight gain is television viewing. The Nurses' Health 
Study identified a 23% increase in obesity with frequent television watching (Hu FB, 
Li TY, Colditz GA, Willett WC, 2003). 
C. Non-Surgical Obesity Interventions 
i. Diet 
Non-surgical interventions for the treatment of obesity include four 
modalities: diet, physical exercise, behavior modification, and medications (Mun EC, 
Blackbum GL, Matthews JB, 2001). Dietary interventions include moderate calorie 
restriction and very low calorie diets (VLCDs). VLCDs consist of an energy intake of 
29 
200_800 kilocalories daily (Bray G, 1998). Individuals presenting with a BMI greater 
than 30 kg/m2 and have failed other weight loss approaches might be prescribed a 
VLCD under close medical supervision. Although this approach promotes rapid initial 
weight loss, long-term efficacy is lacking (Wadden TA, Foster GD, Letizia KA, 1994). 
Moderate calorie restriction is more balanced in terms of nutrient content and consists 
of a caloric deficit of 500-1000 kilocalories daily, promoting a weight loss of 
approximately Yz-1 kilogram weekly. 
A recent study by Dansinger and colleagues compared four commercial diets 
(Weight Watchers, Omish, Atkins, and Zone) on dietary compliance along with 
weight loss outcomes and CVD risk factor improvements. The 160 participants in this 
study were randomized to one of the above commercial diets. They were advised to 
follow these diets per dietary protocol for two months at which time participants were 
able to adhere to the diets per self-selection. All measured outcomes at one year were 
self-reported by participants. Those participants that completed the study had more 
weight loss and improvements in CVD risk factors compared to those that did not 
complete the study. All of the diets significantly improved participants' cholesterol 
ratio; however, there were no differences in blood pressure and blood glucose at one 
year. Participants with greater dietary compliance had more weight loss and 
improvement in CVD risk factors. Among the four diets, total mean weight loss was at 
one year was 2.1 to 3.3 kilograms indicating modest weight loss (Dansinger ML, 
Gleason JA, Griffith JL, Selker HP, Schaefer EJ). 
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ii. Exercise 
Physical activity and exercise are important elements in successful weight loss 
interventions. Some studies have reported limited or no weight loss implementing 
physical activity and exercise without adjunct dietary therapy (Garrow JS, Summerbell 
CD, 1995). However, interventions combining diet and exercise have been effective. 
In regards to the health benefits from exercise, several studies have reported beneficial 
health effects such as improvement of diabetes and cardiovascular disease (Tremblay 
A, Despres JP, Maheux J, Pouliot MC, Nadeau A, Moorjani S, Lupien PJ, Bouchard 
C, 1991; Ekelund LG, Haskell WL, Johnson JL, Whaley FS, Criqui MH, Sheps DS. 
1988). 
iii. Behavior Therapy 
Behavior therapy seeks to identify the barriers preventing adherence to dietary 
and physical activity interventions important for the promotion of weight reduction 
and weight maintenance. This therapy has shown to be effective in conjunction with 
diet therapy. In fact, long-term follow-up of patients has indicated weight regain 
without behavior therapy (Wadden TA, Foster GD, Letizia KA, 1994). The 
Identification, Evaluation and Treatment of Overweight and Obesity in Adults NIH 
Expert Panel recommends that weight reduction and weight maintenance programs 
consist of both dietary and behavior therapy for the promotion and maintenance of 
Weight loss (NIH, 1998). 
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. Pharmacotherapy JV. 
Phannacotherapy for the promotion of weight loss includes two primary 
based on their mode of action: appetite suppression and initiation of classes 
thennogenesis and intestinal fat malabsorption or both. (Bray GA, 1993). Currently, 
there are several weight loss medications in use: Orilstat, an inhibitor of pancreatic 
lipase promoting malabsorption of dietary trigylcerides (Hauptman JB, Jeunet FS, 
Hartman D, 1992); Sibutramine, an anorexiant (Rolls BJ, Shide DJ, Thorwart ML, 
Ulbrecht JS, 1998); and Phentermine, an anorexiant (Bray GA, 1993). These 
medications are most effective when prescribed in adjunct with diet therapy, behavior 
therapy, and exercise (Wadden TA, Berkowitz RI, Sarwer DB, Prus-Wisniewski R, 
Steinberg C, 2001). The efficacy of these medications is variable, most often 
promoting a weight loss up to ten percent based on pre-treatment weight with an 
expected regain of at least some of the weight lost. However, some studies suggest 
that there is less weight regain in those subjects on pharmacotherapy for weight 
reduction (Sjostrom L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar 
HP, KrempfM, 1998; James WP, _1995; Finer N, Bloom SR, Frost GS, Banks LM, 
Griffiths J, 2000). Pharmacotherapy has not promoted significant weight loss for the 
morbidly obese person, and therefore is not considered an efficacious treatment for 
those with a BMI > 40 kg/m2. 
D. Racial Disparities in Obesity and Health 
There are clear ethnic differences in the prevalence of obesity. More than two-
thirds of African American women are considered overweight or obese which is 1.4 
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. greater than Caucasian women (Linquist CH, Gower BA, Goran MI, 2000; 
tunes 
. er RL Hunter GR, Zuckerman PA, Redden DT, Darnell BE, Larson DE, We1sn ' 
Newcomer BR, Goran MI, 2000). The prevalence of obesity as reported by the 
NJfANES 1999-2000 increased by 11.5 % and 7.2 % among African American and 
Caucasian women, respectively, compared to NHANES III (Flegal Km, Carroll MD, 
Ogen CL, Johnson Cl, 2002). 
i. Comorbidities 
Obesity has been shown to be a major risk factor in the development of several 
comorbidities including CVD, diabetes, and certain cancers (Linquist CH, Gower BA, 
Goran MI, 2000). Obesity in African Americans is associated with diabetes and 
hypertension. African Americans have double the risk of developing CVD and type 2 
diabetes compared to Caucasians (Harris MI, 1990). Complications associated with 
type 2 diabetes; such as retinopathy, nephropathy, neuropathy, and lower extremity 
amputations are greater in African Americans than Caucasians (Harris MI, 2001). Data 
suggest that pre- and postmenopaD;sal African American women are more insulin 
resistant than their Caucasian counterparts indicating an increased propensity to 
developing type 2 diabetes (Ryan AS, Nicklas BJ, Beman DM, 2002). Gower et. al. 
found that both premenopausal obese African American and Caucasian women 
showed improvements in HDL cholesterol, total cholesterol, and LDL cholesterol with 
weight loss (Gower BA, Weisner RL, Jordan JM, Hunter GR, Desmond R, 2002). 
The North Carolina WISEWOMAN project showed that obese African American 
women had higher body mass indices but did not show significant differences in the 
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l ce of hypertension compared to their obese Caucasian counterparts. However, preva en 
b se African American women had a significantly higher prevalence of non-o e 
hypertension than non-obese Caucasian women (Nelson TL, Hunt KJ, Rosamond WD, 
.AmJllennan AS, Keyserling TC, Mokdad AH, Will JC, 2002). Weight differences 
between African Americans and Caucasians appear in childhood, which might 
contribute to the increased risk for diabetes and CVD seen in African Americans 
(Straus RS, Pollack HA, 2000; Freedman DS, Srinivasan SR, Valdez RA, Williamson 
OF, Berenson GS, 1997). Due to these racial disparities, it is important to target 
weight loss and the prevention of dsease interventions toward ethnic needs. 
ii. Metabolism 
Ethnic differences in EE have been observed in several studies. Data suggest 
that African Americans have a lower resting energy expenditure (REE) compared to 
their Caucasian counterparts (Sharp TA, Bell ML, Grunwald GK, Schmitz KH, Sidney 
S, Lewis CE, Tolan K, Hill JO, 2002). Gannon et. al. reviewed 15 studies examining 
the effects of energy expenditure parameters on weight loss comparing African 
Americans and Caucasians. Twelve studies found lower EE in African Americans 
using indirect calorimetry and doubly labeled water methods. Two of the five 
remaining studies found that African Americans have lower total daily energy 
expenditure (TDEE) as a result of decreased physical activity energy expenditure 
(PAEE) (Gannon B, DiPietro L, Poehlman ET, 2000). Hunter et. al. suggested that a 
possible reason for this lower REE in African Americans might be from the decreased 
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b l·cally active trunk (organ) tissue found in African Americans compared to meta o i 
·ans (Hunter GR, Weisner RL, Darnell BE, Zuckerman PA, Goran MI, 2000). 
caucas1 
Data suggest that muscle tissue type might have an effect on weight loss with 
Type 1 fibers being more metabolically active compared to type Ilb muscle fibers 
(Tanner CJ, Barakat HA, Lynis Dohrn G, Pories WJ, MacDonald KG, Cunningham 
PRG, Swanson MS, Hournard JA, 2002). Tanner et.al. compared muscle fiber type 
and weight loss outcomes between African American and Caucasian women. Subjects 
were grouped and compared by ethnic background and BMI. Results showed that 
obese African American women had a significantly higher number of type Ilb muscle 
fibers compared to their Caucasian counterparts. Interestingly, this study found a 
positive relationship between the amount of type 1 muscle fibers and the degree of 
weight loss in the obese groups (Tanner CJ, Barakat HA, Lynis Dohrn G, Pories WJ, 
MacDonald KG, Cunningham PRG, Swanson MS, Houmard JA, 2002). 
Lovejoy et. al. examined the disparities in EE and dietary intake between 
premenopausal middle-aged African American and Caucasian women participating in 
the Parent, Healthly Transition Study. Dietary data was collected from food journals 
completed by subjects for four days and analyzed using nutrient analysis computer 
software. Using direct calorimetry, sleep energy expenditure (SEE) was lower in 
African American women compared to Caucasian women. Intake of protein was 
significantly lower in African American women than in their Caucasian counterparts. 
However, no ethnic differences were found in fat and carbohydrate intake (Lovejoy 
JC, Champagne CM, Smith SR, de Jong L, Xie H, 2001). The above findings suggest 
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that ethnic differences in EE and protein intake might have an impact on the 
lence of obesity in African American women. preva 
Foster et.al. compared the effects of weight loss in obese African American 
(BMI 36.8 ± 4.4) and Caucasian (36.1±5.1) women. Subjects included non-smoking 
women without significant medical or psychiatric disorders. Prior to the weight loss 
intervention, REE was measured using indirect calorimetry and was shown to be 
significantly lower in African American women than in Caucasian women. After 
following equivalent dietary plans, African Americans lost 2.5% less weight than 
Caucasian women. African American women had greater reductions in REE than 
Caucasian women after the weight loss intervention suggesting that obese African 
American women have increased efficiency in conserving body weight compared to 
obese Caucasian women resulting from a greater decrease in REE (Foster GD, 
Wadden TA, Swain RM, Anderson DA, Vogt RA, 1999). 
II. Gastric Bypass Surgery (GBP) for the Treatment of Extreme Obesity 
The Roux-en-Y gastric bypass procedure (RYGBP) was first introduced for the 
treatment of morbid obesity in the late 1960's. Edward Mason, MD developed this 
procedure based on the significant weight loss outcomes from patients following 
partial gastrectomy surgeries (Mason EE, 1992). The RYGBP is now recognized as 
the gold standard treatment for many patients with Class III obesity, especially those 
with serious medical co-morbid conditions. Approximately 109,000 weight loss 
surgeries are performed annually in the US (Klein S, Burke LE, Bray, George, Blair S, 
All" . Ison DB, P1-Sunyer X, Hong Y, Eckel RH, 2004). This procedure has demonstrated 
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t ·nable weight loss with manageable complications both in the short- and long-sus ai 
(Schauer PR, Ikramuddin S, Gourash W, Ramanathan R, Luketich J, 2000). tenn 
The RYGBP is achieved by creating approximately a 30 mL pouch in the 
proximal stomach. The gastric pouch is divided from the remaining distal stomach by 
staples. The transit of food passes from the pouch through a tight outlet or stoma into 
the jejunum while bypassing the duodenum. The small pouch and narrow outlet result 
in restricted calorie intake. Weight loss results primarily from the small pouch 
capacity leading to early satiety and decreased energy intake (Sonnanstine TE, Kim JJ, 
Shikora SA, 2004). 
Bariatric surgeries have proven to be efficacious for long-term weight loss, 
with the RYGBP yielding the greatest benefit with fewer complications (NIH 
Conference Development Conference Panel, 1991). These surgeries predispose 
patients to maldigestion and malabsorption due to the anatomical changes of the 
stomach and small bowel, and the potential for inappropriate dietary and eating 
behaviors. It is critical that patients fully comprehend the dietary and eating behavior 
restrictions following bariatric surgery necessitating comprehensive preoperative 
nutrition education and behavior modification counseling. 
The postoperative care ofbariatric surgery patients should include a 
multidisciplinary approach. The dietitian plays a primary role in this team approach, in 
the prevention and treatment of disordered eating behaviors and nutritional 
deficiencies. Patients with preoperative active eating disorders are not considered 
candidates for bariatric surgery, unless they undergo treatment with documented 
resolution of this behavior prior to surgery. However, disordered eating behavior 
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might develop postoperatively, requiring judicious monitoring by the bariatric team 
(Betsy Lehman Center Expert Panel, 2004). Nutrition support following bariatric 
ry aims to promote adequate nutrition and hydration to ensure homeostatic surge 
support of bodily functions, promote wound healing, and spare lean body mass. The 
post-bariatric surgery diet should be advanced in stages to achieve adequate nutrition 
support and food tolerance (Elliot K, 2003). The following review will delineate the 
primary nutritional considerations following bariatric surgeries including short- and 
long-term medical nutrition therapy. 
A. Energy and Macronutrient Needs 
i. Energy 
Insufficient data is available to provide evidence-based recommendations for 
daily calorie, protein, carbohydrate, and fat intake following bariatric surgery. Caloric 
intake during the first few months postoperatively might be fewer than 1000 
kilocalories daily with a moderate increase during the first year (Moize V, Geliebter 
A, Gluck ME, Yahav E, Lorence E, Colarusso T, Drake V, Flancbaum L, 2003; 
Kenler HA, Brolin RE, Cody RP, .1990; Coughlin K, Bell RM, Bivins BA, Wrobel S, 
Griffen WO Jr, 1983; Betsy Lehman Center Expert Panel, 2004). As dietary intake 
increases after surgery, energy provided varies with the volume of food and fluid that 
is tolerated. Daily caloric intake usually approaches 400 calories for the first four 
weeks postoperatively. Intake can be expected to increase to 800-1000 kilocalories 
daily by the end of the third postoperative month, with weight loss being most rapid 
during this time period (Betsy Lehman Center Expert Panel, 2004). 
38 
Greater than 25% of the total daily calories should come from high quality 
t ·n (60-80 grams daily). Fat intake should be approximately 25-30 % of the total pro e1 
daily kilocalories. As carbohydrate is protein sparing, approximately 40-50 % of the 
remaining energy should be supplied as carbohydrate with at least 100 grams per day 
being recommended for the prevention of ketosis (Betsy Lehman Center Expert Panel, 
2004). 
ii. Protein 
Protein-calorie malnutrition is uncommon in patients who have had gastric 
restrictive surgeries such as the RYGBP and vertical banded gastroplasty (VBG) 
unless an anatomical problem such as stomal stenosis is present leading to poor dietary 
intake (Bryne KT, 2001). Adequate protein intake is encouraged postoperatively for 
improved healing and to maintain adequate visceral protein stores as well as to 
decrease loss of lean body mass. Due to the small capacity of the gastric pouch 
following restrictive surgeries, an increased intolerance to meats might occur. Modular 
and liquid protein supplements 1,11ight be necessary to promote adequate daily protein 
intake. The recommendations for protein intake as indicated by the Betsy Lehman 
Center Weight Loss Surgery Expert Panel are 1-1.5 g/kg ideal body weight (IBW) 
daily (Betsy Lehman Center Expert Panel, 2004). Some programs use adjusted body 
weight (ABW) rather than IBW to estimate macronutrient needs. High biological 
value protein sources such as meats (i.e. chicken, fish) and dairy (i.e. milk, cheese) are 
encouraged to ensure intake of all essential amino acids for the promotion of wound 
healing. 
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As patients become more weight stable, adequate protein intake continues to 
Ouraged for the preservation and restoration of lean body mass and increased be enc 
. t As is widely accepted, adequate energy intake is required for positive nitrogen 
sane Y· 
balance. It has been noted that protein intake and absorption are compromised due to 
gastric restriction and intestinal bypass. Decreased availability of pepsin, rennin, and 
hydrochloric acid might inhibit optimal protein digestion with subsequent intolerances 
(Moize V, Geliebter A, Gluck ME, Yahav E, Lorence M, Colarusso T, Drake V, 
Flancbaum L, 2003). 
Protein malnutrition, particularly the hypoalbuminemic form, is of greatest 
concern following highly malabsorptive surgeries. Postoperative protein requirements 
have been estimated at 90 grams per day from high biological value sources 
(Scopinaro N, Adami GF, Marinari GM, Gianetta E, Traverso E, Friedman D, 
Camerini G, Baschieri G, Simonelli A, 1998). 
iii. Carbohydrate 
Carbohydrate intake is increased gradually postoperatively. Patients should be 
educated on the types and amounts of carbohydrate to consume using resources such 
as the ADA Exchange System (ADA, 1995). Due to limited evidence-based data on 
macronutrient needs following bariatric surgery, recommendations are usually based 
on the Dietary Reference Intakes (DRis) of 2002 (IOM, 2002) and modified to 
individual need. A minimum of 100 grams of carbohydrate per day is recommended to 
prevent ketosis following the second postoperative month (Betsy Lehman Center 
Expert Panel, 2004). 
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Nutrition education focusing on reading food labels is useful to help patients 
'd fioods containing large amounts of sugar. Consumption of such foods might lead 
aVOl 
to the rapid gastric emptying, diarrhea and gastrointestinal discomfort associated with 
dumping syndrome, discussed in greater detail later in this review. Patients should 
choose foods with less than seven grams of sugar per 100-kilocalorie serving. 
Furthennore, patients should be counseled on avoiding foods containing elevated 
levels of sugar alcohols due to their laxative effect (Betsy Lehman Center Expert 
Panel, 2004). 
iv. Fat 
The recommendations for fat intake usually change following most bariatric 
surgeries. Significant decreases in dietary intake usually occur up to one year 
postoperatively as a result of gastric restriction, potential food intolerances, and 
anatomic anomalies. After the first year, fat and carbohydrate intake usually increase 
while protein intake decreases, as patients begin to tolerate a greater variety of foods. 
Those patients who maintain higher protein intake and lower fat intake tend to 
consume fewer calories rendering a better weight loss. This suggests that weight loss 
efficiency following bariatric surgery might be, in part, associated with a decreased 
percentage of total energy from fat. Based on these results, dietary recommendations 
following bariatric surgery should not only focus on total energy intake but also on the 
distribution of calories from protein, carbohydrate, and fat. (Coughlin K, Bell RM, 
Bivins BA, Wrobel S, Griffen WO Jr., 1983). 
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Literature suggests that no more than 25% of total calories should come from 
fat for a healthy diet following bariatric surgery to promote better weight loss and 
weight maintenance (Mallory G, 1992). Small amounts of fat (10 grams) at each meal 
should be encouraged which will assist with maintaining gallbladder emptying and 
minimizing the risk of cholelithiasis, especially during rapid weight loss (Betsy 
Lehman Center Expert Panel, 2004). This is also recommended in patients who have 
had a cholecystectomy, to limit symptoms associated with fat malabsorption. 
In order to provide a more balanced diet, adequate carbohydrate and fat are 
recommended with an emphasis on protein intake (Kenler HA, Brohn RE, Cody RP, 
1990). However, insufficient data is available to provide specific evidence-based 
recommendations for energy and macronutrient intake. It is prudent that future 
research focus on the long-term nutritional needs following bariatric surgeries to help 
prevent weight recidivism and nutritional deficiencies. 
B. Micronutrient Considerations 
Micronutrient deficiencies might occur in all weight loss surgery patients 
regardless of procedure. This is due to reduction in overall food intake and decreased 
consumption of specific foods or classes of foods such as dairy and red meat. Because 
of the limited quantity of food consumed, nutrition support is focused on maximizing 
the quality of these foods (Collene AL, Hertzler SH, 2003). Bariatric surgeries, 
especially malabsorptive procedures, compromise micronutrient absorption as a result 
of the relatively low-acid environment of the gastric pouch, impaired binding to carrier 
proteins, insufficient capacity to liberate food-bound micronutrients, and decreased 
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rptive surfaces of the small bowel. For these reasons, weight loss surgery patients ab so 
t n·sk for several deficiencies including vitamin B 12, folic acid, vitamin D and are a 
other fat-soluble vitamins, calcium, and iron (Elliot K, 2003; Betsy Lehman Center 
Expert Panel, 2004). All preoperative bariatric patients should undergo assessment of 
micronutrient status with repletion of any deficiencies. Since obesity is generally 
associated with normal or supranormal bone mineral density, routine preoperative 
bone density assessment does not appear to be needed; however, assessment might be 
advisable for post-menopausal women or others at high risk for osteoporosis. The 
following pages will discuss the primary micronutrient deficiencies with guidelines for 
prevention and treatment. (Betsy Lehman Center Expert Panel, 2004). 
i. Iron 
Iron is a trace mineral that is involved in oxidation and reduction activities 
involved in cellular respiration. Iron plays a primary role in red blood cell function, 
myoglobin activity, and the utilization of multiple heme and nonheme enzymes 
(Mahan K, Escott-Stump S, 2000). The average adult stores approximately one to 
three grams of iron with a depletion of about one milligram daily, primarily through 
the shedding of cells from the skin and lining of the intestinal mucosa. However, 
menstruating women lose an average of two milligrams daily, increasing their risk for 
iron-deficiency anemia (Betsy Lehman Center Expert Panel, 2004). 
Bariatric surgeries that alter the gut physiology and bypass portions of the 
small intestine compromise digestion and absorption of iron leading to possible iron 
deficiency. Iron absorption occurs in the duodenum and proximal jejunum, which are 
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sed in the RYGBP and other malabsorptive procedures. Iron requires gastric bypas 
.d primarily hydrochloric acid of the stomach, for conversion to its soluble form. 
ac1 ' 
Following gastric restrictive intestinal bypass surgeries, both the acid environment of 
the stomach and available mucosal surface of the small intestine are altered increasing 
the risk for iron deficiency with or without anemia (Kushner R, 2000; Elliot K, 2003). 
Due to the small size of the gastric pouch and decreased acid production, many 
patients have difficulty tolerating meats containing heme iron, the most bioavailable 
form (Moize V, Geliebter A, Gluck ME, Yahav E, Lorence M, Colarusso T, Drake V, 
Flancbaum L., 2003) 
Iron and ferritin should be measured and deficiencies corrected pre- and 
postoperatively for the prevention of iron deficiency and subsequent anemias. Serum 
iron levels tend to decline within the first year after surgery. Supplementation is 
recommended with a downward trend in serum iron levels to prevent the onset of iron-
deficiency anemia (Brohn RE, Gorman RC, Milgrim LM, Kenler HA, 1991). Due to 
declining iron storage over the long-term, lifelong monitoring is recommended. 
Patients presenting with iron deficiency should be instructed to take oral iron 
supplementation within a range of 180-220 milligrams of elemental iron daily for 
repletion of iron stores (Brohn RE, Gorman JH, Gorman RC, Petschenik AJ, Bradley 
LB, Keuler HA, Cody RP, 1998). Menstruating women should receive 40-65 
milligrams of elemental iron prophylactically after gastric restrictive and intestinal 
bypass surgery. Iron sources such as ferrous sulfate, gluconate, or fumarate are usually 
recommended daily along with approximately 500 milligrams of vitamin C (Kushner 
R, 2000). Vitamin C enhances iron absorption due to its role in the conversion from 
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the ferric to the absorbable ferrous form. Iron supplements containing vitamin C are 
ideal for patients to prevent having to take additional supplements (Betsy Lehman 
Center Expert Panel, 2004). 
ii. Vitamin Bl 2 
The primary function of vitamin B 12 is to promote normal metabolism of cells, 
primarily from the nervous system, gastrointestinal tract, and bone marrow (Mahan K, 
Escott-Stump S, 2000). Vitamin B12 deficiency is common following gastric 
restrictive intestinal bypass surgery. 
Contributing factors to vitamin B12 deficiency include food restriction and 
reduced gastric hydrochloric acid, pepsin, and pancreatic enzymes leading to impaired 
release of protein-bound vitamin B12 from foods. Vitamin B12 deficiency might be, 
in part, a result of impaired secretion of intrinsic factor, impaired binding capacity of 
intrinsic factor with vitamin B12, and bacterial overgrowth as a result ofreduced 
motility of the bypassed small intestine (Collene AL, Hertzler SH, 2003). The onset of 
this deficiency is usually after the .first postoperative year because of enterohepatic 
recycling of vitamin B12 and the release of hepatic stores (Collene AL, Hertzler SH, 
2003). Serum vitamin B 12 levels will deplete rapidly without daily multivitamin 
supplementation and adequate dietary intake of vitamin B 12. Patients should be 
counseled on increasing dietary sources of vitamin B12 such as dairy, meat, and eggs. 
Supplementation with crystalline vitamin B12 found in multivitamins might prevent 
deficiency in some patients, and should be prescribed for all postoperative patients not 
identified as deficient. Vitamin B12 supplementation should be initiated in patients 
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nting with suboptimal serum vitamin B12 levels . Oral vitamin B12 prese 
Plementation of at least 350 micrograms per day is usually adequate; however, sup 
with severe deficiency, intramuscular vitamin B 12 is recommended (Elliot K, 2003; 
Betsy Lehman Center Expert Panel, 2004). 
iii. Folate 
Folate, a B vitamin, is a coenzyme involved in the metabolism of nucleotides 
and amino acids (Mahan K, Escott-Stump S, 2000), and plays a primary role in the 
prevention of megaloblastic anemia. The jejunum is the primary site of folate 
absorption; however, some absorption occurs throughout the small bowel (Hunt SM, 
Groff JG, 1990). Approximately 20% of patients develop folate deficiency following 
gastric restrictive intestinal bypass surgery. Bacterial production of folate in the 
proximal large bowel might compensate for some of the decreased folate absorption 
(Collene AL, Hertzler SH, 2003; Kumpf VJ, 1996). Intake of high folate-containing 
food sources such as fortified grains and dark green leafy vegetables should be 
encouraged, when these foods are .reintroduced into the diet. Prevention of deficiency 
can usually be achieved with daily multivitamin supplementation containing 200-400 
micrograms of folate (Betsy Lehman Center Expert Panel, 2004). 
iv. Thiamin 
Thiamin deficiency is rare but has been reported following gastric restrictive 
intestinal bypass surgery (Deitel M, Cowan G, 2000). Thiamin plays an important role 
In energy transformation and neural function. Primary absorption occurs in the 
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. . um but thiamin can also be absorbed throughout the small intestine. Excessive 
JeJUn ' 
vomiting, malnutrition and alcoholism are contributors to thiamin deficiency, 
potentially resulting in cranial nerve palsy, peripheral neuropathies, and the 
encephalopathy associated with Wemicke-Korsakoff syndrome (Mahan K, Escott-
Stump S, 2000). As with folate, deficiency of this B vitamin is most often prevented 
by daily multivitamin supplementation. Oral thiamin supplementation of 
approximately ten milligrams daily is usually effective in correcting mild deficiency; 
however, severe deficiencies require intravenous infusion of 100 milligrams for seven 
to 14 days followed by ten milligrams daily until symptoms resolve (Kushner R, 
2000). All patients should be monitored for thiamin deficiency, as patients without 
preoperative risk factors or concurrent alcohol abuse are at risk for deficiencies. 
vi. Calcium 
Calcium is a mineral essential for the health of bones and teeth, clotting of 
blood, hormone secretion and nerve function, and cardiac and skeletal muscle 
contraction (Hunt SM, Groff JG, 1990). Calcium absorption and utilization is affected 
by many factors. Reduced exposure to sunlight and diets high in oxalates found in 
some leafy green vegetables might result in compromised calcium absorption. Diets 
high in fat, protein, alcohol, and high doses of vitamin A decrease the bioavailability 
of dietary calcium. Caffeine and sodium, in large quantities, might increase urinary 
excretion of calcium (Charles P, 2003). 
Patients undergoing weight loss surgeries are at increased risk for developing 
calcium deficiencies, potentially leading to metabolic bone disease. Contributing 
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S l'nclude: decreased consumption of foods containing calcium and vitamin D; factor 
bypassing the duodenum and proximal jejunum, the primary sites for calcium 
absorption via active transport; and malabsorption of vitamin D (Elliot, 2003). 
Most obese patients have a decreased risk for osteoporosis; however, bone 
mineral density tends to lessen with weight loss, and is usually proportional to the rate 
and degree of weight loss and dietary intake of calcium (Goode LR, Brolin RE, 
Chowdhury HA, Shapses SE, 2004; Brano G, Rodin DA, Pazianas M, Nussey SS, 
1999). Gastric secretions are more acidic prior to surgery, facilitating optimal calcium 
absorption. Following gastric restrictive surgery, the acidic environment lessens due to 
the decreased volume of the gastric pouch, resulting in impaired calcium absorption. 
Calcium absorption can occur throughout the bowel via passive diffusion; however, 
the amount of dietary calcium must increase above the recommended allowances to 
achieve adequate absorption (Kushner R, 2000). 
Calcium deficiency is more difficult to detect than vitamin and iron 
deficiencies. Serum levels are not indicative of calcium status, as multiple 
mechanisms, such as bone demin.eralization, exist to maintain serum calcium (Collene, 
AL, Hertzler, SH, 2003 ; Kushner, R, 2000). Serum calcium is bound to albumin and 
is found free-floating as ionized calcium. Calcium levels might be falsely depleted if 
serum protein levels are low. It is prudent to obtain ionized calcium levels in these 
circumstances (Kushner R, 2000). 
Markers for metabolic bone disease have been observed as early as three 
months after surgery, and include increased alkaline phosphatase levels, reduced 
serum calcium levels, and decreased 25 (OH) vitamin D levels (Coates PS, Fernstrom 
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D Fernstrom MH, Schauer PR, Greenspan SL, 2004). Hypocalcemia occurs more J ' 
frequently with procedures inducing a greater degree of malabsorption. Serum 
calcium, phosphorus, alkaline phosphatase and 25 (OH) vitamin D levels should be 
periodically monitored postoperatively. Long-term consequences of altered calcium 
metabolism have not been well defined (Coates PS, Fernstrom JD, Fernstrom MH, 
Schauer PR, Greenspan SL, 2004). More research is needed to establish conclusive 
evidence with regard to bone health. 
As a result of the potential for metabolic bone disease, the literature suggests 
lifelong daily supplementation of 1200-1500 milligrams of calcium citrate with 
vitamin D in divided doses, as calcium citrate is the most soluble form in the absence 
of gastric acid production (Kushner R, 2000). Supplemental calcium absorption is 
most often increased when taken with meals. However, as parathyroid hormone-
stimulated bone resorption is decreased nocturnally, calcium supplements may be 
taken at bedtime without regard to food (Charles P, 2003). Calcium and iron tend to 
compete for absorption, and therefore should be taken at least one hour apart. 
vi. Vitamin D 
Vitamin D is essential for the regulation of normal serum calcium levels and 
bone health. It is rapidly absorbed in the duodenum, but a greater amount is absorbed 
in the ileum with the aid of pancreatic and biliary secretions. Due to the bypassing of 
the duodenum and upper jejunum in gastric restrictive intestinal bypass surgeries, 
these secretions have less contact with food leading to malabsorption of vitamin D 
(Hunt, SM, Groff JG, 1990; Collene, AL, Hertzler SH, 2003). This is not seen in 
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restrictive bariatric surgeries. However, due to the decreased volume capacity of the 
gastric pouch and variable tolerances to milk-based products, dietary intake is usually 
not adequate. Compliance with taking multivitamins and calcium with vitamin D, 
providing approximately 800 International Units (IUs) protects against this deficiency 
(Dietel M, Cowan G, 2000). Supplementation for vitamin D deficiency ranges from 
10,000-50,000 IUs weekly, tapering as indicated by laboratory indices. In highly 
malabsorptive surgeries, vitamin D supplementation of 400,000 IUs intramuscularly 
per month is recommended (Scopinaro N, Adami GF, Marinari GM, Gianetta E, 
Traverso E, Friedman D, Camerini G, Baschieri G, Simonelli A, 1998). 
C. Hydration 
Hydration guidelines are not well documented in the literature for bariatric 
surgeries. Hydration requirements are most often estimated by energy expenditure, 
age, and body weight. As an estimated 25-50% of excess weight is metabolically 
active tissue, it is prudent to use ABW when calculating daily fluid requirements as 
follows: (ABW =[actual+ (actual-ideal)/4 (or 2 for 50%)]). Generally, an estimate of 
50% is used for those patients presenting with a BMI greater than 50 kg/m2 (The 
Science and Practice of Nutrition Support: A Case-Based Core Curriculum, 2001; 
Marotta RB, 1991). 
Dehydration is commonly seen after gastric restrictive intestinal bypass 
surgeries. Obese patients require greater amounts of fluid than their non-obese 
counterparts to maintain normal fluid balance and homeostasis (Kim JJ, Tarnoff ME, 
Shikora SA, 2003). It is recommended that patients drink no more than eight fluid 
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ounces of water per hour, at least during the first two months following bariatric 
surgery due to increased swelling of the gastric pouch. While on soft solid food, 
patients should wait approximately 30 minutes before and after eating three ounces or 
one cup of solid food to consume fluids. After beginning a low fat diet consisting of 
added fruits, vegetables, and starches, patients should wait approximately one hour 
after meals to drink fluids. Following this fluid intake schedule helps to prevent 
dumping syndrome and vomiting. Non-compliance usually leads to subsequent 
grazing between meals due to increased hunger (Elliot K, 2003) with decreased weight 
loss. It is imperative that clinicians promote and monitor for adequate hydration. 
Following gastric restrictive procedures, consumption of carbonated beverages 
tend to result in gastric sequelae (Elliot K, 2003) such as cramping, bloating, nausea, 
and vomiting. It is recommended that patients abstain from the consumption of 
carbonated beverages, especially during the first six postoperative months. Caffeinated 
beverages such as coffee and tea should be avoided in the short-term following most 
procedures, especially restrictive procedures, due to the potential for increased gastric 
acid secretion with resulting gastr.oesophageal reflux (Boekema PJ, Samsom M, 
Smout AJ, 1999). Caffeine also induces increased urine output , which can increase 
risk for dehydration, particularly during rapid weight loss. Caffeinated beverages in 
moderation may be resumed if hydration is adequate, and the risk for dehydration 
minimal, as determined by laboratory indices and symptomatology (Betsy Lehman 
Center Expert Panel, 2004). 
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D. Dietary Advancement and Eating Behaviors Following Bariatric Surgery 
The importance of thorough nutrition education for bariatric surgery patients 
cannot be overstated. Evidence-based guidelines for dietary advancement have not 
been established for all of the bariatric procedures currently in use. Recommendations 
for dietary advancement following bariatric surgery have been compiled based on 
post-gastrectomy nutritional guidelines. Close monitoring of dietary advancement and 
tolerance by a bariatric dietitian is recommended to avoid potential complications 
(Betsy Lehman Center Expert Panel, 2004). 
Short-term postoperative nutritional considerations include adequate intake of 
protein and fluid and the prevention of vomiting and dumping syndrome. Dumping 
syndrome is characterized by rapid emptying of food into the jejunum increasing the 
osmolarity of intestinal contents with a subsequent influx of fluid into the small 
intestine. It is most common in the early postoperative period and becomes less 
prominent after the first postoperative year (Collene AL, Hertzler SH, 2003). There is 
great individual variability in the degree and severity of symptoms. This syndrome is 
most often precipitated by ingestion of food and beverages with high sugar content, 
and is prominent in gastric restrictive malabsorptive procedures such as the RYGBP. 
To avoid symptoms, patients should be instructed to avoid juices, soda, and other high 
sugar-containing beverages (Collene AL, Hertzler SH, 2003; Elliot K, 2003). Sensitive 
individuals should avoid large doses of sugar alcohols; less than five grams per 
serving can be used as a guideline to avoid a laxative effect (Betsy Lehman Center 
Expert Panel, 2004). 
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Several stages of dumping syndrome have been observed. The first stage 
occurs within ten to 20 minutes after eating and usually involves abdominal bloating, 
tachycardia, diaphoresis, flushing, and lightheadedness. The intermediate stage occurs 
approximately 20 to more than 60 minutes following a meal and presents as abdominal 
bloating, cramping, flatulence, and diarrhea. Finally, late stage dumping occurs one-
to-three hours following a meal and is more often a consequence of reactive or 
alimentary hypoglycemia. Symptoms of this stage most often include diaphoresis, 
nervousness, lethargy, shakiness, decreased concentration, and increased hunger 
(Mahan K, Escott-Stump S, 2000). Following gastric restrictive intestinal bypass 
surgeries, food and liquid intake is minimized due to the small size of the gastric 
pouch. Immediately postoperatively, the pouch has a capacity of approximately two 
ounces, but can increase anywhere from two and a half to nine ounces over time 
(Flanagan L, 1996). Due to the small pouch size, it is important for the patient and 
dietitian to focus on incorporating high-quality, nutrient-dense foods. Fluid and 
protein goals must be established in achievable, realistic amounts based on the reduced 
gastric capacity and early satiety of the bariatric surgery patient. 
The bariatric surgery diet progresses in a series of stages beginning with 
liquids and progressively increases in texture. There is great variation among 
programs in the rate of diet advancement due, in large part, to individual differences in 
tolerance and readiness to advance (Elliot K, 2003; Marcasan W, 2004). The standard 
postoperative diet consists of five to six stages, progressing over a two-month period. 
In the immediate postoperative period, patients consume no food or fluid by 
mouth for approximately 24 hours, and are supported with intravenous solutions of 
53 
t Ose saline or lactated ringers to provide adequate hydration. It is recommended dex: r ' 
that this therapy be continued until patients tolerate a full liquid diet for a minimum of 
24 hours. Amino acid/saline intravenous solutions are sometimes provided; however, 
there is no literature indicating this therapy will result in preservation of visceral 
protein given the small amount of calories provided and the short duration of the 
therapy (Betsy Lehman Center Expert Panel, 2004). 
Stage I of the diet is initiated approximately 24 hours after surgery, and 
consists of 30 mL per hour of water for a 24-hour period. If tolerated, patients are 
advanced to Stage II, consisting of no-added sugar clear liquids for another 24 hours. 
No-added sugar full liquids are provided in Stage III, for another 24 hours. In the 
absence of complications, patients are normally discharged after 24 hours on a Stage 
III diet. Postoperative outpatient follow up visits are scheduled with both the surgeon 
and the dietitian. At this time patients are instructed to begin the Stage IV high-protein 
soft-solid diet three weeks after surgery, as tolerated. Patients remain on the Stage IV 
diet for approximately one month. Advancement to the Stage V low-fat solid diet 
occurs, when the patient demonstrates tolerance to soft solids. Patients continue on the 
low-fat diet indefinitely with modifications made as needed (Betsy Lehman Center 
Expert Panel, 2004). 
Although not well documented in the scientific literature, there appear to be 
common food intolerances. Typically, patients have difficulty tolerating milk, red 
meat, dry or tough poultry or pork, bread or doughy starches, and vegetables high in 
insoluble fiber (Collene AL, Hertzler SH, 2003). Over time, tolerance to these foods 
often improves. Tolerance to diet advancement is facilitated by eating slowly, chewing 
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foods thoroughly, avoiding tough-textured meats, and drinking a minimum of 30 
minutes before or after meals. Postoperative vomiting is often subsequent to 
inappropriate eating behaviors. However, vomiting can also be sign of an anatomical 
problem such as an anastomatic stricture or stenosis, which should be ruled out if 
vomiting persists. Intractable vomiting can potentially lead to serious nutritional 
sequalae such as protein energy malnutrition (PEM) and thiamin deficiency. PEM is 
rnore likely to occur in highly malabsorptive procedures such as biliopancreatic 
diversion (BPD) (Marcason W, 2004; Knol, JA, 1994). Appendix B illustrates a series 
of basic recommendations for each stage of the diet following most bariatric surgeries. 
There is a need for long-term studies to determine the macro- and micro-
nutrient requirements for patients following bariatric surgery for weight loss. Current 
recommendations are based on requirements for weight loss, and specific 
complications that arise from the various similar surgical procedures as highlighted 
earlier in this review. Dietitians play an important role as a member of the medical 
team to help prevent nutrient deficiencies, and maximize nutritional intake for 
improved tolerance while preserving the desired rate of weight loss. Familiarity with 
potential complications of each procedure can help the dietitian and patient prevent 
and, if necessary, treat any feeding difficulties. 
E. Restrictive Surgeries: An Overview 
General nutrition recommendations for restrictive surgeries are largely 
mechanical in nature. Patients are encouraged to consume small amounts of food, with 
some variability depending on the size of the pouch created. Typically, one cup of 
55 
food is well tolerated at each sitting. To prevent macro- and micronutrient 
deficiencies, small, frequent meals containing nutrient-dense foods are recommended. 
Patients are encouraged to chew food thoroughly, until the bolus is nearly liquefied, 
prior to swallowing. This will aid in digestion, and help to allow the food to pass 
through the small outlet from the stomach into the small intestine. Generally, 
micronutrient deficiencies are uncommon, as absorptive capacity is unchanged. If 
patients are unable to consume adequate calories to provide the recommended daily 
intake ofmicronutrients supplementation should be considered (MacDonald KG Jr, 
2001). 
Nausea, vomiting, bloating, and reflux are some of the complications that 
might result from inadequate chewing, and consuming portions of food that are too 
large for the pouch size created. These complications might compromise the integrity 
of the staple line, and contribute to band erosion in gastric band procedures 
(Sonnanstine TE, Kim JJ, Shikora SA, 2004). Record keeping is useful to help patients 
identify types and quantities of food, which might cause discomfort, distress, or 
intolerance. As with any bariatric sµrgery, patients are encouraged to avoid high-
calorie liquids and concentrated sweets, which might slow the rate of weight loss, or 
even result in weight gain and displace nutrient-dense foods (Kenler HA, Brohn RE, 
Cody RP, 1990). 
Postoperative onset of disordered eating can occur as a result of induced 
vomiting to relieve discomfort after overeating. Binge eating behavior can decrease 
the integrity of the gastric pouch, and increase the volume capacity, which allows for 
mcreased calorie ingestion with decreased weight loss efficiency. To avoid 
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discomfort, patients tend to consume soft, high-calorie foods and liquids such as ice 
am creamed soups, and juices. Increased gastric volume can lead to outlet ere ' 
obstruction, symptoms of which include vomiting and gastroesophageal reflux 
(MacDonald KG Jr, 2001). 
F. Combination Surgeries: An Overview 
i. Biliopancreatic Diversion (BPD) with and without Duodenal Switch 
BPD combines partial gastrectomy with intestinal bypass, with the greatest 
impact of weight loss resulting from malabsorption. While the weight loss is greater 
than that seen in RYGBP, the surgery carries an increased risk oflong-term nutritional 
complications. It has been postulated that modification of the length of the bypassed 
intestinal limb might allow for desired weight loss, while minimizing malabsorptive 
complications (Scopinaro N, Adami GF, Marinari GM, Gianetta E, Traverso E, 
Friedman D, Camerini G, Baschieri G, Simonelli A, 1998). 
For up to one year postoperatively, dietary recommendations are similar to 
those described earlier in this review. Patients may return to preoperative eating habits 
within one year after BPD surgery without discomfort or impact on weight loss, due to 
the effect of intestinal adaptation (Scopinaro N, Adami GF, Marinari GM, Gianetta E, 
Traverso E, Friedman D, Camerini G, Baschieri G, Simonelli A, 1998). Fewer side 
effects have been demonstrated with the duodenal switch procedure, although the 
incidence of the most troublesome side effects of abdominal bloating and malodorous 
stool was relatively unchanged. The degree of micronutrient deficiency appears to be 
decreased with the duodenal switch approach, but it is recommended that patients be 
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monitored for these deficiencies (Marceau P, Hould FS, Simard S, Lebel S, Bourque 
RA, Potvin M, Biron S, 1998). 
G. Special Considerations 
i. Nutrition Support 
Nutrition support guidelines following gastric restrictive intestinal bypass 
surgeries generally are the same as for the postoperative gastrointestinal surgery 
patient. Enteral nutrition may be utilized if a gastrostomy feeding tube was placed 
during the bariatric procedure. If enteral access is not available, and the patient is 
expected to be NPO more than seven days, total parenteral nutrition (TPN) may be 
initiated. Contraindications to TPN are usually the same as for gastrointestinal surgery 
patients in the presence of critical illness and sepsis. Bariatric surgery patients might 
be at risk for refeeding syndrome if they have been NPO or on clear liquids for as few 
as 48 hours prior to initiation of nutrition support. Judicious monitoring of electrolytes 
and fluid balance is recommended while advancing nutrition support. Guidelines for 
advancement have been established by the American Society for Parenteral and 
Enteral Nutrition (ASPEN) and others, and are appropriate for the bariatric surgery 
patient as well (The Science and Practice ofNutrition Support, 2001). 
ii. Pregnancy 
Pregnancy following weight loss surgery is considered high risk and should be 
postponed for at least one year or until patients have reached a stable weight and 
nutritional status. Pre-pregnancy assessment and planning is prudent to identify and 
ameliorate micronutrient deficiencies prior to pregnancy. Prenatal vitamins are 
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recommended in addition to prescribed vitamin and mineral supplementation as 
preparation for pregnancy, and should continue throughout pregnancy (Wittgrove A, 
l998; Preziosi P, 1997). 
Iron requirements for women are greater in pregnancy and vary with each 
trimester. During the first trimester, iron needs are reduced as a result of amenorrhea. 
However, during the second trimester, as the plasma volume and red blood cell mass 
increases close to 50% and 40%, respectively, iron needs also increase. Bariatric 
surgery resulting in decreased intake of iron-containing foods due to intolerance and 
altered digestion and absorption require prudent monitoring during pregnancy to 
prevent the onset of iron-deficiency anemia. If patients present with iron deficiency 
with or without anemia, iron supplementation should be initiated. Ferrous fumerate is 
often tolerated and absorbed better by most patients following surgery (Wittgrove A, 
1998). 
To prevent the onset of iron deficiency, women should exhibit iron stores of 
more than 300 milligrams prior to pregnancy. Iron supplementation of 30 milligrams 
daily during the second trimester is recommended. However, 60 milligrams is 
recommended for women presenting with a pre-pregnancy iron deficiency. Iron 
supplements should be taken between meals to decrease gastric irritation and to 
increase absorption (Bothwell TH, 2000). 
H. Efficacy of Gastric Bypass Surgery 
The RYGBP results in a weight loss of 65-80% of excess body weight at 1-1.5 
years and 50-60% at five years after surgery. Given the efficacy of weight loss, 
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bariatric surgeries including the RYGBP are considered the most effective 
interventions for morbid obesity. Outcomes of the gastric bypass procedure not only 
include effective weight loss but also improve obesity comorbidities (Stocker DJ, 
2003). 
i. Weight Reduction 
The negative impact of obesity on the morbidity and mortality rates in the US 
cannot be ignored. Conservative approaches to promote weight loss have shown to be 
ineffective. Many traditional diets have promoted weight loss and subsequent 
recidivism. GBP improves both weight loss rates and degree of weight loss along with 
subsequent improvements in cardiovascular and metabolic sequelae (Schauer PR, 
Ikramuddin S, Gourash W, Ramanathan R, Luketich J, 2000). In a small number of 
clinical studies, it was reported that morbidly obese African American women lose 
weight less efficiently and show less improvement in blood pressure than their 
Caucasian counterparts following GBP (Schauer PR, Ikramuddin S, Gourash W, 
Ramanathan R, Luketich J, 2000). 
GBP has been shown to promote a 66% loss of excess weight in patients one to 
two years following surgery, 60% at five years, and 50% at ten years (Sugerman HJ, 
2001). Sugerman et.al. showed that African American patients lost less weight 
compared to Caucasian patients following the laparoscopic adjustable silicone gastric 
handing. The African American patients lost 11.5% ± 18% of their excess weight in 
contrast to Caucasians losing 44% ± 26% at two years following GBP (DeMaria EJ, 
Sugennan HJ, Meador JG, Doty JM, Kellum JM, Wolfe L, Szucs RA, Turner M, 
2001 ). These racial disparities are important to acknowledge for targeting 
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postoperative medical nutrition therapy to the needs of each ethnic group. This should 
promote better weight loss and long-term weight maintenance. 
ii. Comorbidities 
Sugerman et.al. examined the relationship between diabetes and hypertension 
in a cohort of severely obese patients prior to and following GBP. The effects of race, 
age, gender, percent of excess weight loss, and the relationship of comorbidities such 
as obstructive sleep apnea and venous stasis were observed. The results suggested that 
the length of time with obesity was positively correlated with the incidences of 
diabetes and hypertension. The patients with a better resolution of hypertension and 
diabetes proved to have a greater percentage of excess weight loss and tended to be 
younger and Caucasian. African American patients did not lose weight as efficiently 
as Caucasians, 58 kg± 16 and 69 kg± 18, respectively (Sugerman HJ, Wolf LG, Sica 
DA, Clore JN, 2003). These ethnic differences are important to address to better 
promote weight loss and health outcomes following weight loss surgery, particularly 
among African Americans. 
Studies have demonstrated significant improvements in cardiovascular risk 
factors and diabetes among Caucasian morbidly obese patients following GBP 
(Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, 
Dahlgren S, Larsson B, Narbro K, Sjostrom CD, Sullivan M, Wedel H, 2004). Similar 
studies in other ethnic groups remain limited. This might be related to the less frequent 
use ofbariatric surgery in minority populations (Choban P, Lu B, Flancbaum L, 2000; 
Livingston EH, Ko CY, 2004). Although there might be metabolic differences 
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between morbidly obese African Americans and Caucasians, behavioral factors such 
as dietary intake might also account for differences in weight reduction between 
African Americans and Caucasians (Foster GD, Wadden TA, Swain RM, Anderson 
DA, Vogt RA, 1999). Clarification of these differences is important for optimizing the 
post-surgical treatment of morbidly obese African Americans. 
Conclusion 
Presently there is limited data examining the differences in weight loss, dietary 
intake, and cardiovascular risk factors between African Americans and Caucasians 
following GBP. This research project looked at these differences and did find that 
African Americans lost less weight compared with Caucasians following GBP. 
Dietary intake appears to be non-contributory to these weight loss differences. 
However, despite smaller weight losses among African Americans, cardiovascular 
improvements were similar between each race. Further research is essential to better 
improve postoperative GBP outcomes among different racial groups. 
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Appendix B 
Common Dietary Stages Following Bariatric Surgery 
Stage I (does not include fluid provided by intravenous infusion) 
Food Type: Water 
Duration: 0-1 day 
Begin: Postoperative day 1 
End: Postoperative day 1 
Amount: 1-2 oz/hr 
Fluid Goal: 14-32 oz/d (based on 14-16 waking hours) 
Protein Goal: 0 g/d 
Stage II 
Food Type: Clear liquids 
Non-caloric, decaffeinated, and noncarbonated beverages 
Duration: 1-2 days 
Begin: Postoperative day 1-2 
End: Postoperative day 2-3 
Amount: 2-3 oz/hr 
Fluid Goal: 32-48 oz/d (based on 14-16 waking hours) 
Protein Goal: 0 g/d 
Other Suggestions: 
Decaffeinated, noncarbonated, sugar-free beverages 
Stage III 
Food Type: Full liquids 
Liquids containing high biological value protein 
Nonfat or low-fat milk, low-fat creamed soups, blended and 
strained sugar-free pudding and custard, blended low-fat cottage 
and ricotta cheese 
Some protocols recommend adding additional protein to these drinks 
through powdered skim milk or powdered egg white (approximately 1 
Tbsp per serving) 
Duration: 14-21 days/2-3 weeks 
Begin: Postoperative day 2-4 
End: Postoperative day 16-25/week 2.5-3.5 
Amount: 3-6 servings of 4-8 oz/d 
Fluid Goal: 48-i2 oz/d, or based on estimated needs 
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(Cont) . 
Protein Goal: 60-80 g/d, or based on estimated needs 
Other Suggestions: 
Sip all liquids slowly, limit to approximately 8 oz/hr 
Stage IV 
Food Type: Pureed/ground/diced foods 
Generally foods allowed include only meat, poultry, fish, tofu and 
dairy products 
Starches: fruits and vegetables are typically excluded from this 
stage although soft fruits and vegetables have been included in 
some protocols 
Duration: 21-42 days/3-6 weeks 
Begin: Postoperative day 17-26/week 2.5-3.5 
End: Postoperative day 38-68/week 5.5-10 
Amount: 2-3 oz of pureed/ground/diced food taken 3-5 times/d 
Fluid Goal: 48-72 oz/d, or based on estimated needs 
0-2 8-oz servings of full liquids (Drinks containing high biological 
value protein) 
Protein Goal: 60-80 g/d, or based on estimated needs 
Other Suggestions: 
Stage V 
Ground beef and shellfish might be difficult to tolerate 
Eat slowly: 10 minutes/oz 
Chew food thoroughly 
Drink fluids at least 1 hour after meals 
Food Type: Small meals/snacks, consisting oflow-fat solids 
Duration: Ongoing 
Begin: Postoperative day 38-68/week 4.5-10 
End: Ongoing 
Amount: Typically based on the American Diabetes Association food exchange list. 
Number of servings tolerated is widely variable by individual. 
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(Cont) 
SAMPLE MEAL PLAN (recommendations might vary based on individual 
filedU 
Starch: 3-7 exchanges 
Fruit (soft): 2-3 exchanges 
Vegetable: 2-4 exchanges 
Milk: 1 exchange 
Meat: 6-9 exchanges 
Fat: 1-5 exchange 
Fluid Goal: 48-72 oz/d, or based on estimated needs 
Protein Goal: 60-80 g/d, or based on estimated needs 
Other Suggestions: 
Make protein the priority food 
Allow a minimum of 10 minutes per ounce of food, or 30 minutes per 3 
ounces 
Often hard starches such as toast and crackers are better tolerated than 
plain bread 
Peel fresh vegetables and fruit when beginning to add in these foods 
Problematic foods typically include the following: 
Red meat, ground beef, dry meats, shellfish, cores, hard skins 
(such as from an apple), seeds, membranes (particularly from 
thick-skinned fruits and vegetables), popcorn kernels, nuts, 
seeds, rice, and pasta 
(Above dietary stages adapted from the Betsy Lehman Center Expert Panel on 
Weight Loss Surgery Report) 
73 
Bibliography 
Allison DB, Fontaine KR, Manson JE, Stevens J, Vanltalle TB. Annual deaths 
attributable to obesity in the United States. JAMA. 1999; 282 :1530-1538. 
Betsy Lehman Center for Patient Safety and Medical Error Reduction-Expert Panel on 
Weight Loss Surgery (2004), retrieved January 5, 2005, from 
http://www.mass.gov I dph/betsylehman/index .htm. 
Black AE, Prentice AM, Goldberg GR, Jebb SA, Bingham SA, Livingstone MB, 
Coward WA. Measurements of total energy expenditure provide insights into the 
validity of dietary measurements of dietary intake. J Am Diet Assoc. 1993; 93: 
572-9. 
Boekema PJ, Samsom M, Smout AJ. Coffee and gastrointestinal function: facts and 
fiction. A review. Scand J Gastroenterol Suppl. 1999; 230:35-9. 
Bouchard C. Etiology of obesity: genetic factors . Arch Latinoam Nutr. 1992 Sep; 42(3 
Suppl): 127S-130S. 
Bouchard C, Perusse L. Genetics of obesity. Annu Rev Nutr. 1993; 13:337-54. 
Bouchard C, Tremblay A, Despres JP, Nadeau A, Dussault J, Moorjani S, Pinault S, 
Fournier G. The response to long-term overfeeding in identical twins. N Engl J 
Med. 1990.24; 322(21): 1477-82. 
Brano G, Rodin DA, Pazianas, M, Nussey, SS. Reduced bone mineral density after 
surgical treatment for obesity. Int J Obes Re/at Metab Disord. 1999; 23:361-5 . 
Bray GA. Use and abuse of appetite-suppressant drugs in the treatment of obesity. Ann 
Intern Med. 1993;119:707-713. 
Brolin RE, Gorman JH, Gorman RC, Petschenik AJ, Bradley LB, Kenler HA, Cody 
RP. Prophylactic iron supplementation after Roux-en Y gastric bypass: a 
prospective, double blind, randomized study. Arch Surg. 1998; 133(7): 740-744. 
Brolin, RE, Gorman, RC, Milgrim, LM, Kenler, HA. Multivitamin prophylaxis in 
prevention of post-gastric bypass vitamin and mineral deficiencies. Int J Obes. 
1991; 15:661-7. 
Byrne KT. Complications of surgery for obesity. Surg Clin North Am. 2001; 81(5): 
1181-93. 
74 
Carpenter WH, Fonong T, Toth MJ, Ades PA, Calles-Escandon J, Walston JD, 
Poehlman ET. Total daily energy expenditure in free-living older African-
Americans and Caucasians. Am J Physiol. 1998; 274(1Pt1): E96-101. 
Charles P. Calcium absorption and calcium bioavailability. J Internal Med. 2003; 
231 :161-168. 
Chitwood LF, Brown SP, Lundy MJ, Dupper MA. Metabolic propensity toward 
obesity in black vs white females: responses during rest, exercise and recovery. 
Int J Obes. 1996; 20: 455-462. 
Cho ban P, Lu B, Flancbaum L. Insurance decision about obesity surgery: a new type 
of randomization? Obes Surg. 2000; 10(6): 553-6. 
Coates PS, Fernstrom JD, Fernstrom MH, Schauer PR, Greenspan SL. Gastric bypass 
surgery for morbid obesity leads to an increase in bone turnover and a decrease in 
bone mass. J Clin Endocrinol Metab. 2004; 89: 1061-1065 
Collene AL, Hertzler SH. Metabolic Outcomes of Gastric Bypass. Nutr in Clin Prac. 
2003; 18:136-140. 
Coughlin K, Bell RM, Bivins BA, Wrobel S, Griffen WO Jr. Preoperative and 
postoperative assessment of nutrient intakes in patients who have undergone 
gastric bypass surgery. Arch Surg. 1983; 188 (7): 813-816. 
Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ. Comparison of the 
Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart 
disease risk reduction: a randomized trial. JAMA. 2005; 293(1):43-53. 
Deitel M, Cowan G S.M. Surgery for the morbidly obese patient. Lippincott Williams, 
and Wilken; 2000. 
DeMaria EJ, Sugerman HJ, Meador JG, Doty JM, Kellum JM, Wolfe L, Szucs RA, 
Turner MA. High failure rate after laparoscopic adjustable silicone gastric 
banding for treatment of morbid obesity. Ann Surg. 2001; 233(6): 809-18. 
Devlin MJ, Yanovski SZ, Wilson GT.Obesity: what mental health professionals need 
to know. Am J Psychiatry. 2000; 157(6): 854-66. 
DiPietro L, Anda RF, Williamson DF, Stunkard AJ. Depressive symptoms and weight 
change in a national cohort of adults. Int J Obes Re/at Metab Disord. 1992; 
16(10):745-53. 
Drewnowski A. Obesity and the food environment: dietary energy density and diet 
costs. Am J Prev Med.2004.0ct; 27(3 Suppl): 154-62. 
75 
Drewnowski A. The role of energy density. Lipids. 2003; 38(2): 109-15. 
Ekelund LG, Haskell WL, Johnson JL, Whaley FS, Criqui MH, Sheps DS. Physical 
fitness as a predictor of cardiovascular mortality in asymptomatic North American 
men. The Lipid Research Clinics Mortality Follow-up Study. N Engl J Med. 
1988; 319(21): 1379-84. 
Elliot K. Nutritional considerations after bariatric surgery. Critical Care Nursing 
Quarterly. 2003; 26(2): 133-8. 
Exchange Lists for Weight Management. American Diabetes and Dietetic 
Associations, revised 1995. 
Expert Panel. Clinical guidelines on the identification, evaluation, and treatment of 
overweight and obesity in adults: the evidence report. Bethesda, MD: National 
Institute of Health, National Heart Lung, and Blood Institute, U.S. Department of 
Health and Human Services, Public Health Service, 1998. 
Finer N, Bloom SR, Frost GS, Banks LM, Griffiths J. Sibutramine is effective for 
weight loss and diabetic control in obesity with type 2 diabetes: a randomised, 
double-blind, placebo-controlled study. Diabetes Obes Metab. 2000; 2(2): 105-12. 
Flanagan L. Measurement of Functional Pouch Volume following the Gastric Bypass 
Procedure. Obesity Surgery. 1996; 6:38-43. 
Flegal KM, Carroll MD, Ogen CL, Johnson CL. Prevalence and trends in overweight 
among US adults, 1999-2000. JAMA . 2002; 288 (14): 1723-1727. 
Foster GD, Wadden TA, Swain RM, Anderson DA, Vogt RA. Changes in resting 
energy expenditure after weight loss in obese African American and white 
women. Am J Clin Nutr. 1999:69:13-17. 
Freedman DS, Srinivasan SR, Valdez RA, Williamson DF Berenson GS. Secular 
increases in relative weight and adiposity among children over two decades: the 
Bogalusa Heart Study. Pediatrics. 1997; 99: 420-426. 
French SA, Story M, Jeffery RW. Environmental influences on eating and physical 
activity. Annu Rev Public Health. 2001; 22:309-35. 
Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low -
density lipoprotein cholesterol in plasma without use of an ultracentrifuge. Clin 
Chem. 1972; 18:499-502. 
Gannon, B, DiPietro L, and Poehlman, ET. Do African Americans have lower energy 
expenditure than Caucasians? International Journal of Obesity. 2000; 24:4-13 . 
76 
Garrow JS, Summerbell CD. Meta-analysis: effect of exercise, with or without dieting, 
on the body composition of overweight subjects. Eur J Clin Nutr. 1995; 49(1): 1-
10. 
Geissler CA, Aldouri MSH. Racial differences in the energy cost of standardized 
activities. Ann. Nutr. Metab. 1985; 29: 40-47. 
Gidez LI, Miller GO, Burstein M. Separation and quantification of subclasses of 
human plasma high density lipoproteins by a simple precipitation procedure. J 
Lipid Res. 1982; 23:1206-1223. 
Goode, LR, Brolin, RE, Chowdhury, HA, Shapses, SE. Bone and gastric bypass 
surgery: effects of dietary calcium and vitamin D. Obes Res. 2004; 12 (1): 40-47. 
Gortmaker SL, Must A, Sobol AM, Peterson K, Colditz GA, Dietz WH. Television 
viewing as a cause of increasing obesity among children in the United States, 1986-
1990. Arch Pediatr Adolesc Med. 1996; 150(4): 356-62. 
Gower, BA, Weinsier, RL, Jordan, JM, Hunter GR, and Desmond R. Effects of weight 
loss on changes in insulin sensitivity and lipid concentrations in premenopausal 
African American and white women. Am J Clin Nutr. 2002; 76:923-927. 
Harnack LJ, Jeffery RW, Boutelle KN. Temporal trends in energy intake in the United 
States: an ecologic perspective. Am J Clin Nutr. 2000; 71(6): 1478-84. 
Harris Ml. Noninsulin-dependent diabetes mellitus in black and white Americans. 
Diabetes Metab Rev. 1990; 6:71-90. 
Harris Ml. Racial and ethnic differences in health care access and health outcomes for 
adults with type 2 diabetes. Diabetes Care. 2001; (3): 454-9. 
Harris ML, Flegal KM, Cowie CC, Eberthardt MS, Goldstein DE, Little RR, 
Wiedmeyer HM, Byrd-Holt DD. Prevalence of diabetes, impaired fasting glucose, 
and impaired glucose tolerance in US adults: The Third National Health and 
Nutrition Examination Survey, 1988-94. Diabetes Care. 1998; 21:518-524. 
Hauptman JB, Jeunet FS, Hartmann D. Initial studies in humans with the novel 
gastrointestinal lipase inhibitor Ro 18-0647 (tetrahydrolipstatin). Am J Clin Nutr. 
1992; 55:309S-313S. 
Hu FB, Li TY, Colditz GA, Willett WC. Television watching and other sedentary 
behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. 
JAMA. 2003; 9; 289(14): 1785-91. 
Hunt, SM, Groff, JG. Advanced Nutrition and Human Metabolism. West Publishing 
Company; 1990 
77 
Hunter, GR, Weisnier, RL, Darnell, BE, Zuckerman, PA, Goran, MI. Racial 
differences in energy expenditure and aerobic fitness in premenopausal women. 
Am J Clin Nutr. 2000; 71 :500-506. 
James WP. A public health approach to the problem of obesity. Int Jobes Rel Metab 
Disord. 1995; 19(suppl 3): S37-S45. 
Kenler HA, Brolin RE, Cody RP. Changes in eating behavior after horizontal 
gastroplasty and Roux-en-Y gastric bypass. Am J Clin Nutr. 1990; 52:87-92. 
Kim JJ, Tarnoff ME, Shikora SA. Surgical treatment for extreme obesity: Evolution of 
a rapidly growing field. Nutr Clin Pract. 2003; 18:109-123. 
Kinra S, Nelder RP, Lewendon GJ. Deprivation and childhood obesity: a cross 
sectional study of 20,973 children in Plymouth, United Kingdom. J Epidemiol 
Community Health. 2000. 54(6): 456-60. 
Klein S, Burke LE, Bray GA, Blair S, Allison DB, Pi-Sunyer X, Hong Y, Eckel RH. 
Clinical implications of obesity with specific focus on cardiovascular disease: a 
statement for professionals from the American Heart Association Council on 
Nutrition, Physical Activity, and Metabolism. Circulation. 2004; 110(18): 2952-
67. 
Knol JA. Management of the problem patient after bariatric surgery. Gastroenterol 
Clin North Am. 1994; 23(2): 345-69. 
Kumanyika SK, Obarzanek E, Stevens VJ, Hebert PR, Whelton PK. Weight-loss 
experience of black and white participants in NHLBI-sponsored clinical trials. Am 
J Clin Nutr. 1991 Jun; 53(6 Suppl): 1631S-1638S. 
Kumpf, VJ. Parenteral iron supplementation. Nutr Clin Pract. 1996;11:139-146. 
Kushner, R. Managing obese patient after bariatric surgery: A case report of severe 
malnutrition and review of the literature. JPEN. 2000 Mar-Apr; 24(2): 126-132. 
Latner JD, Wetzler S, Goodman ER, Glinski J. Gastric bypass in a low-income, inner-
city population: eating disturbances and weight loss. Obes Res. 2004; 12(60): 
956-961. 
Lefebvre PJ, Scheen AJ. Obesity: causes and new treatments. Exp Clin Endocrinol 
Diabetes. 2001: 109(2): S215-S224. 
Linquist, CH, Gower, BA, and Goran, MI. Role of dietary factors in ethnic differences 
in early risk of cardiovascular disease and type 2 diabetes. Am J Clin Nutr. 2000; 
71 :725-732. 
78 
Lissau I, Sorensen T. Parental neglect during childhood and increased risk of obesity 
in young adulthood. Lancet. 1994; 343(8893): 324-7. 
Livingston EH, Ko CY. Socioeconomic characteristics in the population eligible for 
obesity surgery. Surgery. 2004; 135(3): 288-96. 
Lovejoy JC, Champagne CM, Smith SR, de Jonge L, Xie H. Ethnic differences in 
dietary intakes, physical activity, and energy expenditure in middle-aged, 
premenopausal women: the Healthy Transitions Study. Am J Clin Nutr. 2001; 
74(1): 90-5. 
Lovejoy JC, Smith SR, Rood, JC. Comparison of regional fat distribution and health 
risk factors in middle-aged white and African American women: the Healthy 
Transitions Study. Obes Res. 2001; 9:10-16. 
MacDonald Jr. KG. Bariatric Surgery: A Review. General Surgery News. 2001 ;1-12. 
Mahan, K, Escott-Stump, S. Krause 's Food, Nutrition, & Diet Therapy. Ed L. WB 
Saunders Company A Harcourt Health Sciences Company. 2000 (10). 
Mallory, G. Maximum nutrition, minimum calories. Obes Surg. 1992; 2:375-378 . 
Marcason W. What are the dietary guidelines following bariatric surgery? Journal of 
the American Dietetic Association. 2004; 104(3):487-488. 
Marceau P, Hould FS, Simard S, Lebel S, Bourque RA, Potvin M, Biron S. 
Biliopancreatic Diversion with Duodenal Switch. World J Surg. 1998; 22:947-
954. 
Marotta RB, Floch MH. Diet and Nutrition in Ulcer Disease. Med Clin North Am. 
1991 Jul; 75(4): 967-79. 
Mason EE. Gastric surgery for morbid obesity. Surg Clin North Am. 1992; 72(2): 501-
13. 
Moize V, Geliebte A, Gluck ME, Yahav E, Lorence M, Colarusso T, Drake V, 
Flancbaum L. Obese patients have inadequate protein intake related to protein 
intolerance up to 1 year following Roux-en-Y gastric bypass. Obes Surg. 2003; 
13:23-28. 
Mun EC, Blackbum GL, Matthews JB. Current Status of Medical and Surgical 
Therapy for Obesity. Gastroenterology 2001;120:669-681. 
Nelson TL, Hunt KJ, Rosamond, WD, Ammerman, AS, Keyserling, TC, Mokdad, 
AH, and Will, JC. Obesity and associated coronary heart disease risk factors in a 
79 
population of low -income African - American and White women: The North 
Carolina WISEWOMAN Project. Prevention Medicine. 2002; 35:1-6. 
National Academy of Sciences' Institute of Medicine. Dietary Reference Intakes for 
Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino 
Acids, 2002. 
NIH Conference Development Conference Panel: Gastrointestinal surgery for severe 
obesity. Ann Intern Med 115:956-961, 1991. 
O'Connell TL. An overview of obesity and weight loss surgery. Clinical Diabetes. 
2004; 22(3): 115-120. 
Pennington J.A.T. Bowes and Church's Food Values of Portion Commonly 
used.1989, 15th edition. 
Pereira MA, Kartashov AI, Ebbeling CB, Van Hom L, Slattery ML, Jacobs DR Jr, 
Ludwig DS. Fast-food habits, weight gain, and insulin resistance (the CARDIA 
study):15-year prospective analysis. Lancet. 2005; 365(9453):36-42. 
Preziosi P. Effect of iron supplementation on the iron status of pregnant women: 
consequence for newborns. J Clin Nutr. 1997; 66: 1178-82. 
Price RA, Reed DR, Guido NJ. Resemblance for body mass index in families of obese 
African American and European American women. Obes Res. 2000; 8:360-366. 
Racette SB, Horowitz JF, Mittendorfer B,Klein S. Racial differences in lipid 
metabolism in women with abdominal obesity. Am J Physiol Regulatory 
Integrative Comp Physiol. 2000; 279:R944-R950. 
Residori L, Garcia-Lorda P, Flancbaum L, Pi-Sunyer X, Laferrere B. Prevalence of 
co-morbidities in obese patients before bariatric surgery: effect of race. Obes 
Surg. 2003; 13: 333-340. 
Rolls BJ, Shide DJ, Thorwart ML, Ulbrecht JS. Sibutramine reduces foods intake in 
humans. Am J Clin Nutr.1998; 6:1-11. 
Ryan, AS, Nicklas, BJ, Berman, DM. Racial differences in insulin resistance and mid-
thigh fat deposition in postmenopausal women. Obes Res. 2002; 10: 336-344. 
Schauer PR, Ikramuddin S, Gourash W, Ramanathan R, Luketich J: Outcomes after 
laparoscopic Roux-En-Y gastric bypass for morbid obesity. Ann Surg. 2000; 
232:515-529. 
Schoeller DA. Measurement of energy expenditure in free-living humans by using 
doubly labeled water. J Nutr . 1988; 118:1278- 89. 
80 
Scopinaro N, Adami GF, Marinari GM, Gianetta E, Traverso E, Friedman D, 
Camerini G, Baschieri G, Simonelli A.Scopinaro, N. Biliopancreatic Diversion. 
World J Surgery. 1998; 22:936-946. 
Sharp, TA, Bell, ML, Grunwald, GK, Schmitz, KH, Sidney S, Lewis, CE, Tolan, K, 
Hill, JO. Differences in resting metabolic rate between white and African-
American young adults. Obes Res. 2002; 10:726-732. 
Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, 
Dahlgren S, Larsson B, Narbro K, Sjostrom CD, Sullivan M, Wedel H. Lifestyle, 
diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J 
Med. 2004; 351(26): 2683-2693. 
Sjostrom L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP, Krempf 
M. Randomised placebo-controlled trial of orlistat for weight loss and prevention 
of weight regain in obese patients. European Multi centre Orlistat Study Group. 
Lancet. 1998; 352(9123): 167-72. 
Sobal J, Stunkard AJ, 1989 Socioeconomic status and obesity: a review of the 
literature. Psycho! Bull. 1989; 105(2): 260-75 . 
Sonnanstine TE, Kim JJ, Shikora SA. Surgical Options in the Treatment of Morbid 
Obesity: An Overview. Support Line. 2004; 26 (5): 3-17. 
Stocker DJ. Management of the bariatric surgery patient. Endocrinol Metab Clin 
North Am. 2003; 32(2): 437-57. 
Strauss RS, Pollack, HA. Epidemic increase in childhood overweight, 1986-1998. 
JAMA. 2000; 286:2845-2848. 
Sugerman HJ. Bariatric surgery for severe obesity. J Assoc Acad Minor Phys. 2001; 
12(3): 129-136. 
Sugerman HJ, Londrey GL, Kellum JM, WolfL, Liszka T, Engle KM, Birkenhauer R, 
Starkey JV. Weight loss after vertical banded gastroplasty and Roux-en-Y 
gastric bypass for morbid obesity with selective versus random assignment. Am J 
Surg. 1989; 157:93-102. 
Sugerman HJ, Wolf LG, Sica DA, Clore JN. Diabetes and hypertension in severe 
obesity and effects of gastric bypass-induced weight loss. Ann Surg. 2003; 237(6): 
751-756. 
Tanner, CJ, Barakat, HA, Lynis Dohm, G, Pories, WJ, MacDonald, KG, Cunningham, 
PRG, Swanson, MS, and Houmard, JA. Muscle fiber type is associated with 
81 
obesity and weight loss. Am J Physiol Endocrinol Metab. 2002; 282:El 191-
El 196. 
The Science and Practice of Nutrition Support: A Case-Based Core Curriculum. 
Kendall/Hunt Publishing Company 2001. 
Tremblay A, Despres JP, Maheux J, Pouliot MC, Nadeau A, Moorjani S, Lupien PJ, 
Bouchard C. Normalization of the metabolic profile in obese women by exercise 
and a low fat diet. Med Sci Sports Exerc. 1991; 23(12): 1326-31. 
Troiano RP, Frongillo EA Jr, Sobal J, Levitsky DA. The relationship between body 
weight and mortality: a quantitative analysis of combined information from 
existing studies. Int J Obes Relat Metab Disord. 1996; 20:63-75. 
Wadden TA, Berkowitz RI, Sarwer DB, Prus-Wisniewski R, Steinberg C. Benefits of 
lifestyle modification in the pharmacologic treatment of obesity: a randomized 
trial. Arch Intern Med. 2001; 161(2): 218-27. 
Wadden, TA, Foster GD, Letizia KA. One-year behavioral treatment of obesity: 
comparison of moderate and severe caloric restriction and the effects of weight 
maintenance therapy. J Consult Clin Psycho!. 1994; 62:165-171. 
Wardl J, Griffith J. Socioeconomic status and weight control practices in British 
adults. Epidemiol Community Health. 2001; 55(3):185-90. 
Washburn RA, Kline G, Lackland DT, Wheeler FC. Leisure time physical activity: are 
there black/white differences? Prev Med. 1992; 21: 127- 35. 
Weinsier RL, Hunter GR, Heini AF, Goran Ml, Sell SM. The etiology of obesity: 
relative contribution of metabolic factors, diet, and physical activity.Am J Med. 
1998.105(2): 145-50. 
Weinsier RL, Hunter GR, Schutz Y, Zuckerman PA, Darnell BE. Physical activity in 
free-living, overweight white and black women: divergent responses by race to 
diet-induced weight loss. Am J Clin Nutr. 2002; 76(4): 736-42. 
Weisner RL, Hunter GR, Zuckerman PA, Redden DT, Darnell BE, Larson DE, 
Newcomer BR, Goran MI. Energy expenditure and free-living physical activity in 
black and white women: comparison before and after weight loss. Am J Clin Nutr. 
2000; 71: 1138-46. 
Williamson DF, Madans J, Anda RF, Kleinman JC, Kahn HS, Byers T. Recreational 
physical activity and ten-year weight change in a US national cohort. Int J Obes 
Relat Metab Disord. 1993; 17(5): 279-86. 
Wittgrove, A. Pregnancy following gastric bypass for morbid obesity. Obes Surg. 
1998; 461-464. 
82 
World Health Organization: Obesity:preventing and managing the global epidemic: 
report of a WHO consultation. World Health Org Tech Rep Ser.894. 2000. 
World Health Organization: Diet, nutrition and the prevention of chronic diseases 
Report of the joint WHO/F AO expert consultation. World Health Org Tech Rep 
Ser 916. 2003. 
Wurtman RI, Wurtman JJ. Brain serotonin, carbohydrate-craving, obesity and 
depression. Obes Res. 1995; 3 Suppl 4:477S-480S. 
Young LR, Nestle M. The contribution of expanding portion sizes to the US obesity 
epidemic. Am J Public Health. 2002; 92(2) : 246-9 .. 
Zizza C, Siega-Riz AM, Popkin BM.Significant increase in young adults' snacking 
between 1977-1978 and 1994-1996 represents a cause for concern! Prev Med. 
2001; 32(4): 303-10. 
83 
